Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended: March 31, 2024

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from to

Commission file number: 000-49842

CEVA, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	77-0556376
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

15245 Shady Grove Road, Suite 400, Rockville, MD 20850	20850
(Address of Principal Executive Offices)	(Zip Code)

(240)-308-8328

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.001 per share	CEVA	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one).

Large accelerated filer	☐	Accelerated filer	☒

Non-accelerated filer	☐	Smaller reporting company	☐

Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date: 23,582,142 of common stock, $0.001 par value, as of May 6, 2024.

Table of Contents

TABLE OF CONTENTS

		Page
PART I.	FINANCIAL INFORMATION	5
Item 1.	Interim Condensed Consolidated Balance Sheets at March 31, 2024 (unaudited) and December 31, 2023	5
	Interim Condensed Consolidated Statements of Loss (unaudited) for the three months ended March 31, 2024 and 2023	6
	Interim Condensed Consolidated Statements of Comprehensive Loss (unaudited) for the three months ended March 31, 2024 and 2023	7
	Interim Condensed Consolidated Statements of Changes in Stockholders’ Equity (unaudited) for the three months ended March 31, 2024 and 2023	8
	Interim Condensed Consolidated Statements of Cash Flows (unaudited) for the three months ended March 31, 2024 and 2023	9
	Notes to the Interim Condensed Consolidated Financial Statements	10
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	32
Item 4.	Controls and Procedures	33

PART II.	OTHER INFORMATION	33
Item 1.	Legal Proceedings	33
Item 1A.	Risk Factors	33
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	34
Item 3	Defaults Upon Senior Securities	34
Item 4	Mine Safety Disclosures	34
Item 5	Other Information	34
Item 6	Exhibits	35
SIGNATURES		35

Table of Contents

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA

This Quarterly Report contains forward-looking statements that involve risks and uncertainties, as well as assumptions that if they materialize or prove incorrect, could cause the results of CEVA to differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Forward-looking statements are generally written in the future tense and/or are preceded by words such as “will,” “may,” “should,” “could,” “expect,” “suggest,” “believe,” “anticipate,” “intend,” “plan,” or other similar words. Forward-looking statements include the following:

●

Our belief that our portfolio of wireless communications and sensing and edge AI technologies address some of the most important megatrends, including 5G, generative AI, industrial automation and vehicle electrification, and our belief in the continued interest in our IP portfolio due to these trends, in both traditional and new areas;

●

Our belief that our Bluetooth, Wi-Fi, Ultra Wide Band (UWB) and cellular IoT IPs allow us to address the high volume IoT industrial, consumer and smart home markets, and our expectation that the overall addressable market size will be more than 15 billion devices annually by 2027 based on research from ABI Research;

●

Our belief that Wi-Fi represents a significant royalty revenue opportunity in connection with our dominant market position in licensing Wi-Fi 6 and our leadership position in Wi-Fi 7 IP;

●

Our belief that our PentaG2 platform and digital signal processors (DSPs) for 5G mobile broadband and 5G RedCap is the most comprehensive baseband processor IP platform in the industry today and provides newcomers and incumbents with a comprehensive solution to address the need for 5G processing for smartphones, fixed wireless access, satellite communications and a range of connected devices such as robots, cars, smart cities and other devices for industrial applications;

●

Our belief that our PentaG RAN platform for 5G RAN settings is the most comprehensive baseband processor IP in the industry today and provides customers and incumbents with a comprehensive solution to address the need for 5G and other communications in data centers and infrastructure;

●

Our belief that the high volume consumer audio markets, including True Wireless Stereo (TWS) earbuds, smartwatches, AR and VR headsets, and other wearable assisted devices, offers an incremental growth segment for our Bluetooth, Audio AI DSPs and software IPs, and our belief in the capabilities of our RealSpace Spatial Audio & Head Tracking Solution, WhisPro speech recognition technology and ClearVox voice input software to enhance the user experience and offer premium features;

●

Our belief that our SensPro2 sensor hub AI DSP family can address the growing demand for efficient, high-performance signal processing in sensor-based applications across various industries for applications such as smartphones, automotive safety (ADAS), autonomous driving, drones, robotics, security and surveillance, augmented reality (AR) and virtual reality (VR), natural language processing and voice recognition, which enables us to address the transformation in devices enabled by these applications and expand our footprint and content in smartphones, drones, consumer cameras, surveillance, ADAS, voice-enabled devices and industrial IoT applications;

●

Statements regarding third-party estimates of industry growth and future market conditions, including research from Bloomberg Intelligence which forecasts that hardware revenue associated with computer vision AI products and conversational AI devices will reach $61 billion and $108 billion, respectively, by 2030, indicating the size of the market opportunity;

Table of Contents

●

Our belief that our newest generation family of AI neural processing units (NPUs) present a highly efficient and high-performance architecture to enable generative and classic AI on any device including communication gateways, optically connected networks, cars, notebooks and tablets, AR/VR headsets, smartphones, and any other cloud or edge use case from the edge all the way to the cloud, and that more than 2.5 billion Edge AI devices will ship annually by 2026 based on research from Yole Group;

●

Our belief that our sensor fusion and spatial audio application software allows us to address an important technology piece used in personal computers, robotics, TWS earbuds, smart TVs and many other smart sensing IP products, in addition to our existing portfolio for camera-based computer vision and AI processing, and microphone-based sound processing;

●

Our belief that our customers can benefit from our capabilities as a complete, one-stop-shop for processing all classes and types of sensors;

●

Our belief that we are well positioned for long-term growth in shipments and royalty revenues derived from smart edge products as a result of our focus on silicon and software IP solutions that enable products to connect, sense and infer data;

●

Our belief that our ubiquitous technology and collaborative business model present a significant and secular growth prospect as the continuing digital transformation drives industries to become connected and intelligent;

●

Our intention to continue to capitalize on the semiconductor momentum with our portfolio of technologies to enable three main use cases associated with smart edge devices – connect, sense and infer, and to focus on four main markets which include consumer, automotive, industrial and infrastructure, and our belief that such markets are large, diversified and represent the greatest opportunities for long-term growth;

●

Any statements regarding sales trends and financial results for the second, third and fourth quarter of and full year 2024 and other future periods, including our expectations with respect to future customers, contracts, revenues and expenses, regarding our customer pipeline, that a significant portion of our future revenues will continue to be generated by a limited number of customers in part due to consolidation in the semiconductor industry, that international customers will continue to account for a significant portion of our revenues for the foreseeable future, that an increasing portion of our new customers and revenues will be derived from international customers generally and sales to the Asia Pacific and China in particular, that we can expand our customer base and revenues in Europe and the U.S., and that we will experience year-over-year revenue growth in 2024;

●

Our belief that our cash and cash equivalents, short-term bank deposits and marketable securities, along with cash from operations, will provide sufficient capital to fund our operations for at least the next 12 months; and

●

Our belief that fluctuations in high interest rates within our investment portfolio will not have a material effect on our financial position on an annual or quarterly basis.

Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. The forward-looking statements contained in this report are based on information that is currently available to us and expectations and assumptions that we deem reasonable at the time the statements were made. We do not undertake any obligation to update any forward-looking statements in this report or in any of our other communications, except as required by law. All such forward-looking statements should be read as of the time the statements were made and with the recognition that these forward-looking statements may not be complete or accurate at a later date.

Many factors may cause actual results to differ materially from those expressed or implied by the forward-looking statements contained in this report. These factors include, but are not limited to, those risks set forth in Part II – Item 1A – “Risk Factors” of this Form 10-Q.

This report contains market data prepared by third party research firm. Actual market results may differ from their projections.

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

U.S. dollars in thousands, except share and per share data

	March 31, 2024			December 31, 2023

ASSETS
Current assets:
Cash and cash equivalents	$	21,222		$	23,287
Short-term bank deposits		10,662			10,556
Marketable securities		126,870			132,695
Trade receivables (net of allowance for credit losses of $288 at both March 31, 2024 and December 31, 2023)		33,635			30,307
Prepaid expenses and other current assets		13,378			12,526
Total current assets		205,767			209,371
Long-term assets:
Severance pay fund		6,897			7,070
Deferred tax assets, net		1,239			1,609
Property and equipment, net		7,157			6,732
Operating lease right-of-use assets		6,704			6,978
Goodwill		58,308			58,308
Intangible assets, net		2,689			2,967
Investments in marketable equity securities		346			406
Other long-term assets		12,332			10,644
Total long-term assets		95,672			94,714
Total assets	$	301,439		$	304,085

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Trade payables	$	1,804		$	1,154
Deferred revenues		2,479			3,018
Accrued expenses and other payables		4,984			5,800
Accrued payroll and related benefits		14,854			14,402
Operating lease liabilities		2,634			2,513
Total current liabilities		26,755			26,887
Long-term liabilities:
Accrued severance pay		7,339			7,524
Operating lease liabilities		3,525			3,943
Other accrued liabilities		1,471			1,390
Total long-term liabilities		12,335			12,857
Stockholders’ equity:
Preferred Stock: $0.001 par value: 5,000,000 shares authorized; none issued and outstanding		—			—
Common Stock: $0.001 par value: 45,000,000 shares authorized; 23,695,190 shares issued at March 31, 2024 and December 31, 2023. 23,581,522 and 23,440,848 shares outstanding at March 31, 2024 and December 31, 2023, respectively		24			23
Additional paid in-capital		252,927			252,100
Treasury stock at cost (113,668 and 254,342 shares of common stock at March 31, 2024, and December 31, 2023, respectively)		(2,528	)		(5,620	)
Accumulated other comprehensive loss		(2,720	)		(2,329	)
Retained earnings		14,646			20,167
Total stockholders’ equity		262,349			264,341
Total liabilities and stockholders’ equity	$	301,439		$	304,085

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

Table of Contents

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF LOSS (UNAUDITED)

U.S. dollars in thousands, except per share data

	Three months ended
	March 31,
	2024			2023
Revenues:
Licensing and related revenue	$	11,414		$	18,248
Royalties		10,658			8,014
Total revenues		22,072			26,262
Cost of revenues		2,503			3,508
Gross profit		19,569			22,754
Operating expenses:
Research and development, net		17,991			18,674
Sales and marketing		2,816			2,719
General and administrative		3,572			3,827
Amortization of intangible assets		150			154
Total operating expenses		24,529			25,374
Operating loss		(4,960	)		(2,620	)
Financial income, net		1,257			1,455
Remeasurement of marketable equity securities		(60	)		(117
Loss from continuing operation before taxes on income		(3,763	)		(1,282	)
Income tax expense		1,685			1,417
Net loss from continuing operation		(5,448	)		(2,699	)
Discontinued operation (Note 4):
Net loss from discontinued operation		—			(2,173
Net loss	$	(5,448	)	$	(4,872	)

Basic and diluted net loss per share from continuing operation	$	(0.23	)	$	(0.12
Basic and diluted net loss per share from discontinued operation	$	—		$	(0.09	)
Basic and diluted net loss per share	$	(0.23	)	$	(0.21	)


Weighted-average shares used to compute net loss per share (in thousands):
Basic and diluted		23,508			23,334

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

Table of Contents

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)

U.S. dollars in thousands

	Three months ended
	March 31,
	2024			2023

Net loss:	$	(5,448	)	$	(4,872	)
Other comprehensive income (loss) before tax:
Available-for-sale securities:
Changes in unrealized gains (losses)		200			730
Reclassification adjustments for gains included in net loss		(4	)		(92	)
Net change		196			638
Cash flow hedges:
Changes in unrealized gains (losses)		(195	)		(425	)
Reclassification adjustments for (gains) losses included in net loss		(380	)		171
Net change		(575	)		(254	)
Other comprehensive income (loss) before tax		(379	)		384
Income tax expense related to components of other comprehensive income (loss)		12			45
Other comprehensive income (loss), net of taxes		(391	)		339
Comprehensive loss	$	(5,839	)	$	(4,533	)

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

Table of Contents

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)

U.S. dollars in thousands, except share data

	Common stock
Three months ended March 31, 2024	Number of shares outstanding			Amount		Additional paid-in capital			Treasury stock			Accumulated other comprehensive income (loss)			Retained earnings			Total stockholders’ equity
Balance as of January 1, 2024		23,440,848		$	23	$	252,100		$	(5,620	)	$	(2,329	)	$	20,167		$	264,341
Net loss		—			—		—			—			—			(5,448	)		(5,448	)
Other comprehensive loss, net		—			—		—			—			(391	)		—			(391	)
Equity-based compensation		—			—		3,571			—			—			—			3,571
Purchase of treasury stock		(56,872	)		—		—			(1,278	)		—			—			(1,278	)
Issuance of treasury stock upon exercise of stock-based awards		197,546			1		(2,744	)		4,370			—			(73	)		1,554
Balance as of March 31, 2024		23,581,522		$	24	$	252,927		$	(2,528	)	$	(2,720	)	$	14,646		$	262,349

	Common stock
Three months ended March 31, 2023	Number of shares outstanding		Amount		Additional paid-in capital			Treasury stock			Accumulated other comprehensive income (loss)			Retained earnings			Total stockholders’ equity
Balance as of January 1, 2023		23,215,439	$	23	$	242,841		$	(9,904	)	$	(6,249	)	$	32,160		$	258,871
Net loss		—		—		—			—			—			(4,872	)		(4,872	)
Other comprehensive income		—		—		—			—			339			—			339
Equity-based compensation		—		—		3,859			—			—			—			3,859
Issuance of treasury stock upon exercise of stock-based awards		200,587		—		(3,559	)		5,232			—			—			1,673
Balance as of March 31, 2023		23,416,026	$	23	$	243,141		$	(4,672	)	$	(5,910	)	$	27,288		$	259,870

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

U.S. dollars in thousands

	Three months ended March 31,
	2024			2023
Cash flows from operating activities:
Net loss	$	(5,448	)	$	(4,872	)
Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation		700			742
Amortization of intangible assets		278			677
Equity-based compensation		3,571			3,859
Realized gain on sale of available-for-sale marketable securities		(4	)		(92	)
Amortization of premiums (accretion of discount) on available-for-sale marketable securities		(191	)		23
Unrealized foreign exchange (gain) loss		165			(285	)
Remeasurement of marketable equity securities		60			117
Changes in operating assets and liabilities:
Trade receivables, net		(3,003	)		(3,802	)
Prepaid expenses and other assets		(3,194	)		(2,205	)
Operating lease right-of-use assets		274			249
Accrued interest on bank deposits		(106	)		(125	)
Deferred tax, net		358			(880	)
Trade payables		433			(412	)
Deferred revenues		(539	)		838
Accrued expenses and other payables		(973	)		357
Accrued payroll and related benefits		510			702
Operating lease liability		(235	)		(275	)
Accrued severance pay, net		(6	)		308
Net cash used in operating activities		(7,350	)		(5,076	)

Cash flows from investing activities:
Purchase of property and equipment		(904	)		(105	)
Proceeds from the sale of Intrinsix (see note 4)		540			—
Asset acquisition		(753	)		—
Investment in available-for-sale marketable securities		(12,653	)		—
Proceeds from maturity of available-for-sale marketable securities		14,080			1,750
Proceeds from sale of available-for-sale marketable securities		4,789			4,895
Net cash provided by investing activities		5,099			6,540

Cash flows from financing activities:
Purchase of treasury stock		(1,278	)		—
Proceeds from exercise of stock-based awards		1,554			1,673
Net cash provided by financing activities		276			1,673
Effect of exchange rate changes on cash and cash equivalents		(90	)		61
Increase (decrease) in cash and cash equivalents		(2,065	)		3,198
Cash and cash equivalents at the beginning of the period		23,287			21,285
Cash and cash equivalents at the end of the period	$	21,222		$	24,483

Supplemental information of cash-flow activities:
Cash paid during the period for:
Income and withholding taxes	$	873		$	1,860
Non-cash transactions:
Property and equipment purchases incurred but unpaid at period end	$	200		$	234
Right-of-use assets obtained in the exchange for operating lease liabilities	$	303		$	506

Reconciliation of cash and cash equivalents as shown in the condensed consolidated statements of cash flow:

Cash and cash equivalents in the Condensed Consolidated Balance Sheets	$	21,222		$	24,209
Cash and cash equivalents included in assets of discontinued operation	$	—		$	274
Total cash and cash equivalents in the Condensed Consolidated Statements of Cash Flows	$	21,222		$	24,483

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(in thousands, except share data)

NOTE 1:

BUSINESS

The financial information in this quarterly report includes the results of Ceva, Inc. and its subsidiaries (the “Company” or “Ceva”).

Ceva is the leader in innovative silicon and software IP solutions that enable smart edge products to connect, sense, and infer data more reliably and efficiently. With the industry’s only portfolio of comprehensive communications and scalable edge AI IP, Ceva powers the connectivity, sensing, and inference in today’s most advanced smart edge products across consumer IoT, mobile, automotive, infrastructure, industrial, and personal computing. More than 17 billion of the world’s most innovative smart edge products from AI-infused smartwatches, IoT devices and wearables to autonomous vehicles, 5G mobile networks and more are powered by Ceva.

Ceva is a trusted partner to many of the leading semiconductor and original equipment manufacturer (OEM) companies targeting a wide variety of cellular and IoT end markets, including mobile, PC, consumer, automotive, smart-home, surveillance, robotics, industrial and medical. The customers incorporate Ceva’s IP into application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs) that they manufacture, market and sell to consumer electronics companies. Ceva’s application software IP is licensed primarily to OEMs who embed it in their System on Chip (SoC) designs to enhance the user experience, and OEMs also license Ceva’s hardware IP products and solutions for their SoC designs to create power-efficient, intelligent, secure and connected devices.

Ceva’s wireless communications, sensing and edge AI technologies are at the heart of some of today’s most advanced smart edge products. From Bluetooth connectivity, Wi-Fi, ultra-wide band (UWB) and 5G platform IP for ubiquitous, robust communications, to scalable edge AI neural processing unit (NPU) IPs, sensor fusion processors and embedded application software that make devices smarter.

Ceva licenses its portfolio of wireless communications and scalable edge AI IP to its customers, breaking down barriers to entry and enabling them to bring new cutting-edge products to market faster, more reliably, efficiently and economically.

NOTE 2:

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The interim condensed consolidated financial statements have been prepared according to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024, are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2023, contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 7, 2024, have been applied consistently in these unaudited interim condensed consolidated financial statements.

Accounting Standards Recently Adopted by the Company

In June 2022, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The guidance is effective for annual periods beginning after December 15, 2023, with early adoption permitted. The Company adopted ASU 2022-03 as of January 1, 2024. The adoption did not result in a material impact on the Company's interim condensed financial statements.

Accounting Standards Recently Issued, Not Yet Adopted by the Company

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09.

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

(in thousands, except share data)

Use of Estimates

The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, the reported amounts of revenues and expenses during the reporting period, and amounts classified as a discontinued operation. Actual results could differ from those estimates.

NOTE 3:

ACQUISITION

In January 2024, the Company acquired 100% of the equity shares of a privately held, Greek-based company, to extend the research and development resources in the Ceva group. Under the terms of the purchase agreement, the Company agreed to pay an aggregate of approximately $750 paid at closing and approximately $2,100 subject to continued employment and certain performance milestones. The Company has accounted for this acquisition as an asset acquisition. As such, the total purchase consideration was allocated to the assets acquired.

NOTE 4:

HELD FOR SALE AND DISCONTINUED OPERATION

On September 14, 2023, the Company and Intrinsix, then its wholly owned subsidiary, entered into a Share Purchase Agreement (the “Agreement”) with Cadence Design Systems, Inc. (“Cadence”), pursuant to which Cadence agreed to purchase all of the issued and outstanding capital shares of Intrinsix from the Company for $35,000 in cash, subject to other certain purchase price adjustments as provided for in the Agreement (the “Transaction”). The closing of the Transaction occurred on October 2, 2023. At the closing, an amount of $300 from the consideration was deposited with a third-party escrow agent for the purposes of satisfying any additional post-closing purchase price adjustments owed by the Company to Cadence (was fully paid to the Company during the first quarter of 2024), a further amount of $3,500 of the consideration was deposited with the same escrow agent for a period of 18 months as security for the Company’s indemnification obligations to Cadence in accordance with the terms and conditions set forth in the Agreement, and after giving effect to post-closing adjustments resulting in a $240 repayment to the Company during the first quarter of 2024. The Agreement includes certain representations, warranties and covenants of the parties, and the Company also agreed to certain non-competition and non-solicitation terms, which are subject to certain exceptions.

Under ASC 205-20, "Discontinued Operation" when a component of an entity, as defined in ASC 205-20, has been disposed of or is classified as held for sale, the results of its operations, including the gain or loss on its component are classified as discontinued operations and the assets and liabilities of such component are classified as assets and liabilities attributed to discontinued operations; that is, provided that the operations, assets and liabilities and cash flows of the component have been eliminated from the Company’s consolidated operations and the Company will have no significant continuing involvement in the operations of the component.

As a result of the Transaction, Intrinsix's results of operations and asset and liability balances are disclosed as a discontinued operation. All prior periods comparable results of operation, assets and liabilities have been retroactively included in discontinued operations.

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

The following table shows the Company's results of discontinued operation for the below presented period:

	Three months ended March 31, 2023 (unaudited)
Revenues	$	2,473
Cost of revenue		1,807
Gross profit		666
Operating expenses:
Research and development, net		2,117
Sales and marketing		326
General and administrative		221
Amortization of intangible assets		175
Total operating expenses		2,839
Operating loss		(2,173	)
Financial income, net		—
Loss from discontinued operations before taxes on income		(2,173	)
Income tax expense		—
Net loss from discontinued operation	$	(2,173	)

The following table presents cash flows from discontinued operations:

Three months

ended March

31, 2023

(unaudited)

Net cash flows used in operating activities (*)

(1,230

)

(*) Amortization and depreciation allocated to discontinued operation for the three-month period ended March 31, 2023 amounted to $492.

NOTE 5:

REVENUE RECOGNITION

Under ASC No. 606, “Revenue from Contracts with Customers” (“ASC 606”), an entity recognizes revenue when or as it satisfies a performance obligation by transferring intellectual property (“IP”) licenses or services to the customer, either at a point in time or over time. The Company recognizes most of its revenues at a point in time upon delivery when the customer accepts control of the IP. The Company recognizes revenue over time on significant license customization contracts that are in the scope of ASC 606 by using cost inputs to measure progress toward completion of its performance obligations.

Revenues that are derived from the sale of a licensee’s products that incorporate the Company’s IP are classified as royalty revenues. Royalty revenues are recognized during the quarter in which the sale of the product incorporating the Company’s IP occurs. Royalties are calculated either as a percentage of the revenues received by the Company’s licensees on sales of products incorporating the Company’s IP or on a per unit basis, as specified in the agreements with the licensees. When the Company does not receive actual sales data from the customer prior to the finalization of its financial statements, royalty revenues are recognized based on the Company’s estimation of the customer’s sales during the quarter.

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

The following table includes estimated revenue expected to be recognized in future periods related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The estimated revenues do not include amounts of royalties or unexercised contract renewals:

Remainder

of 2024

2025

2026 and

thereafter

Licensing and related revenues

4,028

1,015

322

Disaggregation of revenue:

The following table provides information about disaggregated revenue by primary geographical, use cases for the Company's technology portfolio, and timing of revenue recognition:

	Three months ended March 31, 2024 (unaudited)						Three months ended March 31, 2023 (unaudited)
	Licensing and related revenues		Royalties		Total		Licensing and related revenues		Royalties		Total
Geography
United States	$	383	$	2,155	$	2,538	$	702	$	1,650	$	2,352
Europe and Middle East		601		911		1,512		1,950		859		2,809
Asia Pacific		10,417		7,592		18,009		15,121		5,505		20,626
Other		13		—		13		475		—		475
Total	$	11,414	$	10,658	$	22,072	$	18,248	$	8,014	$	26,262

Use cases for the Company’s technology portfolio
Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT)	$	10,067	$	7,939	$	18,006	$	15,924	$	5,665	$	21,589
Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI)		1,347		2,719		4,066		2,324		2,349		4,673
Total	$	11,414	$	10,658	$	22,072	$	18,248	$	8,014	$	26,262

Timing of revenue recognition
Products transferred at a point in time	$	9,453	$	10,658	$	20,111	$	14,621	$	8,014	$	22,635
Products and services transferred over time		1,961		—		1,961		3,627		—		3,627
Total	$	11,414	$	10,658	$	22,072	$	18,248	$	8,014	$	26,262

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

Contract balances:

The following table provides information about trade receivables, unbilled receivables and contract liabilities from contracts with customers:

	March 31, 2024		December 31, 2023

Trade receivables	$	14,052	$	8,433
Unbilled receivables (associated with licensing and related revenue)		9,600		9,735
Unbilled receivables (associated with royalties)		9,983		12,139
Deferred revenues (short-term contract liabilities)		2,479		3,018

The Company receives payments from customers based upon contractual payment schedules; trade receivables are recorded when the right to consideration becomes unconditional, and an invoice is issued to the customer. Unbilled receivables associated with licensing and other include amounts related to the Company’s contractual right to consideration for completed performance objectives not yet invoiced. Unbilled receivables associated with royalties are recorded as the Company recognizes revenues from royalties earned during the quarter, but not yet invoiced, either by actual sales data received from customers, or, when applicable, by the Company’s estimation. Contract liabilities (deferred revenue) include payments received in advance of performance under the contract, and are realized with the associated revenue recognized under the contract.

During the three months ended March 31, 2024, the Company recognized $1,179 that was included in deferred revenues (short-term contract liability) balance at January 1, 2024.

NOTE 6:

LEASES

The Company leases substantially all of its office space and vehicles under operating leases. The Company's leases have original lease periods expiring between 2025 and 2034. Many leases include one or more options to renew. The Company does not assume renewals in its determination of the lease term unless the renewals are deemed to be reasonably certain. Lease payments included in the measurement of the lease liability comprise the following: the fixed non-cancelable lease payments, payments for optional renewal periods where it is reasonably certain the renewal period will be exercised, and payments for early termination options unless it is reasonably certain the lease will not be terminated early.

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

The following is a summary of weighted average remaining lease terms and discount rates for all of the Company’s operating leases:

March 31, 2024

(Unaudited)

Weighted average remaining lease term (years)

3.97

Weighted average discount rates

4.00

Total operating lease cost and cash payments for operating leases were as follows:

	Three months ended March 31,
	2024		2023
	(unaudited)		(unaudited)

Operating lease cost	$	663	$	753
Cash payments for operating leases		622		727

Maturities of lease liabilities are as follows:

The remainder of 2024	$2,082
2025		2,027
2026		880
2027		640
2028		332
2029 and thereafter		621
Total undiscounted cash flows		6,582
Less imputed interest		423
Present value of lease liabilities	$	6,159

NOTE 7:

MARKETABLE SECURITIES

The following is a summary of available-for-sale marketable securities:

	March 31, 2024 (Unaudited)
	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Available-for-sale - matures within one year:
Corporate bonds	$	49,434	$	45	$	(743	)	$	48,736

Available-for-sale - matures after one year through three years:
Corporate bonds		80,935		127		(2,928	)		78,134
Total
	$	130,369	$	172	$	(3,671	)	$	126,870

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

	December 31, 2023
	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Available-for-sale - matures within one year:
Corporate bonds	$	27,690	$	4	$	(243	)	$	27,451

Available-for-sale - matures after one year through three years:
Corporate bonds		108,700		278		(3,734	)		105,244

Total	$	136,390	$	282	$	(3,977	)	$	132,695

The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of March 31, 2024, and December 31, 2023, and the length of time that those investments have been in a continuous loss position:

	Less than 12 months					12 months or greater
	Fair value		Gross unrealized loss			Fair value		Gross unrealized loss
As of March 31, 2024 (unaudited)	$	23,123	$	(147	)	$	76,036	$	(3,524	)
As of December 31, 2023	$	18,193	$	(49	)	$	86,643	$	(3,928	)

As of March 31, 2024, the allowance for credit losses was not material.

The following table presents gross realized gains and losses from sale of available-for-sale marketable securities:

	Three months ended March 31,
	2024			2023
	(unaudited)			(unaudited)

Gross realized gains from sale of available-for-sale marketable securities	$	9		$	92
Gross realized losses from sale of available-for-sale marketable securities	$	(5	)	$	—

NOTE 8:

FAIR VALUE MEASUREMENT

FASB ASC No. 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value. Fair value is an exit price, representing the amount that would be received for selling an asset or paid for the transfer of a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:

Level I	Unadjusted quoted prices in active markets that are accessible on the measurement date for identical, unrestricted assets or liabilities;
Level II	Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
Level III	Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

The Company measures its marketable securities, investments in marketable equity securities and foreign currency derivative contracts at fair value. The carrying amount of cash, cash equivalents, short-term bank deposits, trade receivables, other accounts receivable, trade payables and other accounts payables approximate fair value due to the short-term maturity of these instruments. Investments in marketable equity securities are classified within Level I as the securities are traded in an active market. Marketable securities and foreign currency derivative contracts are classified within Level II as the valuation inputs are based on quoted prices and market observable data of similar instruments.

The table below sets forth the Company’s assets and liabilities measured at fair value by level within the fair value hierarchy. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

Description	March 31, 2024 (unaudited)		Level I (unaudited)		Level II (unaudited)		Level III (unaudited)
Assets:
Marketable securities:
Corporate bonds	$	126,870		—	$	126,870		—
Foreign exchange contracts		413		—		413		—
Investments in marketable equity securities		346		346		—		—

Description	December 31, 2023		Level I		Level II		Level III
Assets:
Marketable securities:
Corporate bonds	$	132,695		—	$	132,695		—
Foreign exchange contracts		988		—		988		—
Investments in marketable equity securities		406		406		—		—

NOTE 9:

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA

Summary information about geographic areas:

The Company manages its business on the basis of one reportable segment: the licensing of intellectual property to semiconductor companies and electronic equipment manufacturers (see Note 1 for a brief description of the Company’s business). The following is a summary of revenues within geographic areas:

	Three months ended March 31,
	2024 (unaudited)		2023 (unaudited)
Revenues based on customer location:
United States	$	2,538	$	2,352
Europe and Middle East		1,512		2,809
Asia Pacific (1)		18,009		20,626
Other		13		475
	$	22,072	$	26,262

(1) China	$	13,592	$	17,763

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

Major customer data as a percentage of total revenues:

The following table sets forth the customers that represented 10% or more of the Company’s total revenues in each of the periods set forth below.

	Three months ended March 31,
	2024 (unaudited)			2023 (unaudited)

Customer A		15	%			*)
Customer B		14	%			*)
Customer C			*)		14	*)

*) Less than 10%

NOTE 10:

NET LOSS PER SHARE OF COMMON STOCK

Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period, plus dilutive potential shares of common stock considered outstanding during the period, in accordance with FASB ASC No. 260, “Earnings Per Share.”

	Three months ended March 31,
	2024 (unaudited)			2023 (unaudited)
Numerator:
Net loss from continuing operation	$	(5,448	)	$	(2,699	)
Net loss from discontinued operation		—			(2,173	)
Net loss	$	(5,448	)	$	(4,872	)
Denominator (in thousands):
Basic and diluted weighted-average common stock outstanding		23,508			23,334

Basic and diluted net loss per share from continuing operation	$	(0.23	)	$	(0.12	)
Basic and diluted net loss per share from discontinued operation	$	—		$	(0.09	)
Basic and diluted net loss per share	$	(0.23	)	$	(0.21	)

The total number of shares related to outstanding equity-based awards was 1,560,454 and 1,181,119 for the three months ended March 31, 2024 and 2023, respectively, and in each case was excluded from the calculation of diluted net loss per share.

NOTE 11:

COMMON STOCK AND STOCK-BASED COMPENSATION PLANS

The Company has historically granted a mix of stock options, stock appreciation rights (“SARs”) capped with a ceiling and restricted stock units (“RSUs”) to employees and non‑employee directors of the Company and its subsidiaries under the Company’s equity plans and provides the right to purchase common stock pursuant to the Company’s 2002 employee stock purchase plan to employees of the Company and its subsidiaries. As of March 31, 2024, and December 31, 2023, there were no outstanding or exercisable SARs left.

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

The options granted under the Company’s stock incentive plans have been granted at the fair market value of the Company’s common stock on the grant date. Options granted to employees under stock incentive plans generally vest at a rate of 25% of the shares underlying the option after one year and the remaining shares vest in equal portions over the following 36 months, such that all shares are vested after four years. A summary of the Company’s stock option activities and related information for the three months ended March 31, 2024, are as follows:

	Number of options			Weighted average exercise price		Weighted average remaining contractual term		Aggregate intrinsic value
Outstanding as of December 31, 2023		99,425		$	20.74		2.5	$	316
Granted		—			—
Exercised		(13,000	)		14.77
Forfeited or expired		—			—
Outstanding as of March 31, 2024 (unaudited)		86,425		$	21.64		2.6	$	213
Exercisable as of March 31, 2024 (unaudited)		67,000		$	21.64		1.5	$	192

As of March 31, 2024, there was $184 of unrecognized compensation expense related to unvested stock options. This amount is expected to be recognized over a weighted-average period of 2.2 years.

An RSU award is an agreement to issue shares of the Company’s common stock at the time the award or a portion thereof vests. RSUs granted to employees generally vest in three equal annual installments starting on the first anniversary of the grant date. RSUs granted to non-employee directors would generally vest in two equal annual installments starting on the first anniversary of the grant date.

On February 12, 2024, the Compensation Committee of the Board (the “Committee”) granted 33,318, 20,043, 16,399 and 13,535 RSUs, effective as of February 16, 2024, to each of the Company’s Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), Chief Operating Officer (“COO”) and Chief Commercial Officer (“CCO”), respectively, pursuant to the Company’s 2011 Stock Incentive Plan (the “2011 Plan”). The RSU grants vest 33.4% on February 16, 2025, 33.3% on February 16, 2026 and 33.3% on February 16, 2027.

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

Also, on February 12, 2024, the Committee granted 49,978, 13,362, 10,932 and 9,023 performance-based restricted stock units (“PSUs”), effective as of February 16, 2024, to each of the Company’s CEO, CFO, COO and CCO, respectively, pursuant to the 2011 Plan. The performance goals for the PSUs with specified weighting are as follows:

Weighting	Goals
50% (*)	Vesting of the full 50% of the PSUs occurs if the Company achieves the 2024 license and related revenue target approved by the Board (the “2024 License Revenue Target”). The vesting threshold is achievement of 90% of the 2024 License Revenue Target. If the Company’s achievement of the 2024 License Revenue Target is above 90% but less than 99% of the 2024 License Revenue Target, 91% to 99% of the eligible PSUs would be subject to vesting. If the Company’s actual result exceeds 100% of the 2024 License Revenue Target, every 1% increase of the 2024 License Revenue Target, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO.
25%	Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2024 is greater than the S&P Semiconductors Select Industry index (the “S&P index”). The vesting threshold is if the return on the Company’s stock for 2024 is at least 90% of the S&P index. If the return on the Company’s stock, in comparison to the S&P index, is above 90% but less than 99% of the S&P index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company’s stock exceeds 100% of the S&P index, every 1% increase in comparison to the S&P index, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO.
25%	Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2024 is greater than the Russell 2000 index (the “Russell index”). The vesting threshold is if the return on the Company’s stock for 2024 is at least 90% of the Russell index. If the return on the Company’s stock, in comparison to the Russell index, is above 90% but less than 99% of the Russell index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company’s stock exceeds 100% of the Russell index, every 1% increase in comparison to the Russell index, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO.

(*) As of March 31, 2024, the Company's management estimates that it is not probable that the performance condition will be met by year end.

Accordingly, assuming maximum achievement of the performance goals set forth above, PSUs representing an additional 60%, meaning an additional 29,986, would be eligible for vesting of the Company’s CEO, and an additional 40%, meaning an additional 5,344, 4,372 and 3,609, would be eligible for vesting for each of the Company’s CFO, COO and CCO, respectively.

Subject to achievement of the thresholds the above performance goals for 2024, the PSUs vest 33.4% on February 16, 2025, 33.3% on February 16, 2026 and 33.3% on February 16, 2027.

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

A summary of the Company’s RSU and PSU activities and related information for the three months ended March 31, 2024, are as follows:

	Number of RSUs and PSUs			Weighted Average Grant- Date Fair Value
Unvested as of December 31, 2023		1,281,751		$	24.97
Granted		414,572			17.21
Vested		(112,076	)		36.71
Forfeited or expired		(110,218	)		19.07
Unvested as of March 31, 2024 (unaudited)		1,474,029		$	22.34

As of March 31, 2024, there was $22,830 of unrecognized compensation expense related to unvested RSUs and PSUs. This amount is expected to be recognized over a weighted-average period of 1.6 years.

The following table shows the total equity-based compensation expense included in the interim condensed consolidated statements of loss:

	Three months ended March 31,
	2024 (unaudited)		2023 (unaudited)
Cost of revenue	$	203	$	206
Research and development, net		2,007		2,102
Sales and marketing		365		378
General and administrative		996		866
Total equity-based compensation expense from continuing operations		3,571		3,552
Equity-based compensation expense included in discontinued operations		—		307
Total equity-based compensation expense	$	3,571	$	3,859

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

The fair value for rights to purchase shares of common stock under the Company’s employee stock purchase plan was estimated on the date of grant using the following assumptions:

	Three months ended March 31
	2024 (unaudited)			2023 (unaudited)
Expected dividend yield		0	%		0	%
Expected volatility		46	%		45	%
Risk-free interest rate		5.3	%		4.8	%
Contractual term of up to (months)		6			6

NOTE 12:

DERIVATIVES AND HEDGING ACTIVITIES

The Company follows the requirements of FASB ASC No. 815,” Derivatives and Hedging” which requires companies to recognize all of their derivative instruments as either assets or liabilities in the statement of financial position at fair value. The accounting for changes in fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging transaction and further, on the type of hedging transaction. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. Due to the Company’s global operations, it is exposed to foreign currency exchange rate fluctuations in the normal course of its business. The Company’s treasury policy allows it to offset the risks associated with the effects of certain foreign currency exposures through the purchase of foreign exchange forward or option contracts (“Hedging Contracts”). The policy, however, prohibits the Company from speculating on such Hedging Contracts for profit. To protect against the increase in value of forecasted foreign currency cash flow resulting from salaries paid in currencies other than the U.S. dollar during the year, the Company instituted a foreign currency cash flow hedging program. The Company hedges portions of the anticipated payroll of its non-U.S. employees denominated in the currencies other than the U.S. dollar for a period of one to twelve months with Hedging Contracts. Accordingly, when the dollar strengthens against the foreign currencies, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the Hedging Contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency expenses is offset by gains in the fair value of the Hedging Contracts. These Hedging Contracts are designated as cash flow hedges.

For derivative instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. As of March 31, 2024, and December 31, 2023, the notional principal amount of the Hedging Contracts to sell U.S. dollars held by the Company was $8,700 and $16,500, respectively.

The fair value of the Company’s outstanding derivative instruments is as follows:

	March 31, 2024		December 31, 2023
Derivative assets:
Derivatives designated as cash flow hedging instruments:
Foreign exchange forward contracts	$	413	$	988
Total	$	413	$	988

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

The increase (decrease) in unrealized gains (losses) recognized in “accumulated other comprehensive gain (loss)” on derivatives, before tax effect, is as follows:

	Three months ended March 31,
	2024 (unaudited)			2023 (unaudited)
Derivatives designated as cash flow hedging instruments:
Foreign exchange option contracts	$	—		$	(105	)
Foreign exchange forward contracts		(195	)		(320	)
	$	(195	)	$	(425	)

The net (gains) losses reclassified from “accumulated other comprehensive gain (loss)” into income are as follows:

	Three months ended March 31,
	2024 (unaudited)			2023 (unaudited)
Derivatives designated as cash flow hedging instruments:
Foreign exchange option contracts	$	—		$	—
Foreign exchange forward contracts		(380	)		171
	$	(380	)	$	171

The Company recorded in cost of revenues and operating expenses a net gain of $380 and a net loss $171 during the three months ended March 31, 2024 and 2023, respectively, related to its Hedging Contracts.

NOTE 13:

ACCUMULATED OTHER COMPREHENSIVE LOSS

The following tables summarize the changes in accumulated balances of other comprehensive income (loss), net of taxes:

	Three months ended March 31, 2024 (unaudited)									Three months ended March 31, 2023 (unaudited)
	Unrealized gains (losses) on available- for- sale marketable securities			Unrealized gains (losses) on cash flow hedges			Total			Unrealized gains (losses) on available- for- sale marketable securities			Unrealized gains (losses) on cash flow hedges			Total

Beginning balance	$	(3,317	)	$	988		$	(2,329	)	$	(6,142	)	$	(107	)	$	(6,249	)
Other comprehensive income (loss) before reclassifications		188			(195	)		(7	)		684			(426	)		258
Amounts reclassified from accumulated other comprehensive income (loss)		(4	)		(380	)		(384	)		(92	)		173			81
Net current period other comprehensive income (loss)		184			(575	)		(391	)		592			(253	)		339
Ending balance	$	(3,133	)	$	413		$	(2,720	)	$	(5,550	)	$	(360	)	$	(5,910	)

Table of Contents

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)

The following table provides details about reclassifications out of accumulated other comprehensive income (loss):

Details about Accumulated Other Comprehensive Income (Loss) Components	Amount Reclassified from Accumulated Other Comprehensive Income (Loss)					Affected Line Item in the Statements of Income (Loss)

	Three months ended March 31,
	2024 (unaudited)		2023 (unaudited)
Unrealized losses on cash flow hedges	$	8	$	(4	)	Cost of revenues
		324		(147	)	Research and development
		9		(4	)	Sales and marketing
		39		(16	)	General and administrative
		380		(171	)	Total, before income taxes
		—		2		Income tax expense (benefit)
		380		(173	)	Total, net of income taxes
Unrealized gains on available-for-sale marketable securities		4		92		Financial income (loss), net
		—		—		Income tax expense (benefit)
		4		92		Total, net of income taxes
	$	384	$	(81	)	Total, net of income taxes

NOTE 14:

SHARE REPURCHASE PROGRAM

During the three months ended March 31, 2024, the Company repurchased 56,872 shares of common stock at an average purchase price of $22.48 per share for an aggregate purchase price of $1,278. The Company did not repurchase any shares of common stock during the first quarter of 2023. As of March 31, 2024, 643,128 shares of common stock remained available for repurchase pursuant to the Company’s share repurchase program.

The repurchases of common stock are accounted for as treasury stock, and result in a reduction of stockholders’ equity. When treasury shares are reissued, the Company accounts for the reissuance in accordance with FASB ASC No. 505-30, “Treasury Stock” and charges the excess of the repurchase cost over issuance price using the weighted average method to retained earnings. The purchase cost is calculated based on the specific identified method. In the case where the repurchase cost over issuance price using the weighted average method is lower than the issuance price, the Company credits the difference to additional paid-in capital.

Table of Contents

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion together with the unaudited financial statements and related notes appearing elsewhere in this quarterly report. This discussion contains forward-looking statements that involve risks and uncertainties. Any or all of our forward-looking statements in this quarterly report may turn out to be wrong. These forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Factors which could cause actual results to differ materially include those set forth under in Part II – Item 1A – “Risk Factors,” as well as those discussed elsewhere in this quarterly report. See “Forward-Looking Statements.”

The financial information presented in this quarterly report includes the results of Ceva, Inc. and its subsidiaries.

BUSINESS OVERVIEW

Headquartered in Rockville, Maryland, Ceva is the leader in innovative silicon and software IP solutions that enable smart edge products to connect, sense, and infer data more reliably and efficiently. With the industry’s only portfolio of comprehensive communications and scalable edge AI IP, Ceva powers the connectivity, sensing, and inference in today’s most advanced smart edge products across consumer IoT, mobile, automotive, infrastructure, industrial, and personal computing. More than 17 billion of the world’s most innovative smart edge products from AI-infused smartwatches, IoT devices and wearables to autonomous vehicles, 5G mobile networks and more are powered by Ceva.

Ceva is a trusted partner to over 400 of the leading semiconductor and original equipment manufacturer (OEM) companies targeting a wide variety of cellular and IoT end markets, including mobile, PC, consumer, automotive, smart-home, surveillance, robotics, industrial and medical. The customers incorporate our IP into application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs) that they manufacture, market and sell to consumer electronics companies. Our application software IP is licensed primarily to OEMs who embed it in their System on Chip (SoC) designs to enhance the user experience, and OEMs also license our hardware IP products and solutions for their SoC designs to create power-efficient, intelligent, secure and connected devices.

We licenses our portfolio of wireless communications and scalable edge AI IP to our customers, breaking down barriers to entry and enabling them to bring new cutting-edge products to market faster, more reliably, efficiently and economically.

Ceva is a sustainability and environmentally conscious company. We have adopted both a Code of Business Conduct and Ethics and a Sustainability Policy, in which we emphasize and focus on environmental preservation, recycling, the welfare of our employees and privacy – which we promote on a corporate level. At Ceva, we are committed to social responsibility, values of preservation and consciousness towards these purposes.

We believe our portfolio of wireless communications and sensing and edge AI technologies address some of the most important megatrends, including 5G, generative AI, industrial automation and vehicle electrification. We continue to experience strong interest across our IP portfolio due to these trends, in both traditional and new areas. In the first quarter of 2024, eleven IP licensing deals were concluded for a range of wireless and smart sensing use cases.

We believe the following key elements represent significant growth drivers for the company:

	●	Our broad Bluetooth, Wi-Fi, UWB and cellular IoT IPs allow us to address the high volume IoT industrial, consumer and smart home markets. Our addressable market size for Bluetooth, Wi-Fi, UWB and cellular IoT is expected to be more than 15 billion devices annually by 2027 based on research from ABI Research. In the first quarter of 2024, we signed strategic licensing deals for our next-generation Bluetooth 6 and Wi-Fi 7 IPs, reinforcing our market leading position for these technologies. In particular, we believe that Wi-Fi presents a significant royalty revenue opportunity, given our dominant market position in licensing Wi-Fi 6 with more than 40 customers to date and leadership position in Wi-Fi 7 IP.

	●	Our PentaG2 platform and digital signal processors (DSPs) for 5G mobile broadband and 5G RedCap is the most comprehensive baseband IP platform in the industry today and provides newcomers and incumbents with a comprehensive solution to address the need for 5G processing for fixed wireless access, satellite communications and a range of connected devices such as robots, cars, smart cities and other devices for industrial applications. Indicative of the demand for our 5G Ips, in the first quarter of 2024, we signed three deals for 5G new use cases, two of which target RedCap and one for 5G V2X.

Table of Contents

	●	Our PentaG RAN platform for 5G RAN settings is the most comprehensive baseband processor IP in the industry today and provides newcomers and incumbents with a comprehensive solution to address the need for 5G and other communications in data centers and infrastructure.

	●	The high-volume consumer audio markets, including True Wireless Stereo (TWS) earbuds, smartwatches, AR and VR headsets, and other wearable assisted devices, offers an incremental growth segment for us for our Bluetooth, Audio AI DSPs and software IPs. For OEMs to better address this market, our RealSpace Spatial Audio & Head Tracking Solution and ClearVox voice input software are available to enhance the user experience and offer premium features.

	●	Our SensPro2 sensor hub AI DSP family is designed to address the growing demand for efficient, high-performance signal processing in sensor-based applications across various industries and applications such as smartphones, automotive safety (ADAS), autonomous driving (AD), drones, robotics, security and surveillance, augmented reality (AR) and virtual reality (VR), natural language processing (NLP) and voice recognition. Research from Bloomberg Intelligence forecasts that hardware revenue associated with computer vision AI products and conversational AI devices will reach $61 billion and $108 billion, respectively by 2030, indicating the size of the market opportunity. This sensor hub AI DSP enables us to address the transformation in devices enabled by these applications, and expand our footprint and content in smartphones, drones, consumer cameras, surveillance, automotive ADAS, voice-enabled devices and industrial IoT applications.

	●	Transformer and classic neural networks are increasingly being deployed in a wide range of devices in order to make these devices “smarter.” Our newest generation family of AI NPUs present a highly-efficient and high performance architecture to enable generative and classic AI on any device including communication gateways, optically connected networks, cars, notebooks and tablets, AR/VR headsets, smartphones, and any other cloud or edge use case from the edge all the way to the cloud. Per research from Yole Group, 2.5 billion Edge AI devices will ship annually by 2026, illustrating the huge potential of the market.

	●	Our sensor fusion and spatial audio application software allows us to address an important technology piece used in personal computers, robotics, TWS earbuds, smart TVs and many other smart sensing IP products, in addition to our existing portfolio for camera-based computer vision and AI processing, and microphone-based sound processing. MEMS-based inertial and environmental sensors are used in an increasing number of devices, including robotics, smartphones, laptops, tablets, TWS earbuds, spatial audio headsets, remote controls and many other consumer and industrial devices. Our innovative and proven MotionEngine™ software supports a broad range of merchant sensor chips and is processor-agnostic in order to address the requirements of any OEM or semiconductor company that wishes to enhance their customer user experience. The MotionEngine software has already shipped in more than 300 million devices, indicative of its market traction and excellence. Along with our SensPro sensor hub AI DSPs, our licensees now benefit from our capabilities as a complete, one-stop-shop for processing all classes and types of sensors.

As a result of our focus on silicon and software IP solutions that enable products to connect, sense, and infer data, we believe we are well positioned for long-term growth in shipments and royalty revenues derived from smart edge products. Royalty rates from these products are comprised of a range of ASPs, spanning from high volume Bluetooth and Wi-Fi to high value sensor fusion and base station RAN. The royalty ASP of our other products will be in between the two ranges.

CURRENT TRENDS

We believe that as the continuing digital transformation drives industries to become connected and intelligent, our ubiquitous technology and collaborative business model present a significant and secular growth prospect. We intend to continue to capitalize on the semiconductor momentum with our portfolio of technologies to enable three main use cases associated with smart edge devices: connect, sense and infer. We intend to focus on four main markets, which are consumer, automotive, industrial and infrastructure, which we believe are large, diversified and represent the greatest opportunities for long-term growth. We will also continue to serve the mobile and PC markets where we have established customers and market presence. We believe our key customers are keenly receptive to our products roadmap around connect, sense and infer, and that they are willing to expand the scope of engagements with us as our roadmap aligns with their technology needs. Furthermore, we anticipate that we can expand our customer base and revenues in Europe and the U.S., complementing our strong presence in China, Taiwan, Japan and the remainder of the APAC region.

In 2024, we believe our strategy will return Ceva to year-over-year revenue growth, with overall revenue expected to grow 4% to 8% over 2023. Most of this growth is expected to be concentrated in the second half of the year, In 2024, we expect our licensing and related revenues business will continue to expand into new markets and use cases in the industrial IoT (IIoT) and consumer IoT, offering connectivity platforms, sensing platforms and software, AI solutions (including AI engines, NPUs and software) and more. On royalties, we expect our connectivity products to continue to show strength in 2024, particularly related to our Bluetooth, Wi-Fi and cellular IoT business lines, with the expected ramp of automotive ADAS royalties in the second half of the year. The smartphone market related revenues have continued to decrease for us in recent years due to these trends.

Table of Contents

Instability in the Middle East

Our operations in Israel remain largely unaffected by the war between Israel and Hamas that began on October 7, 2023, and we continue to drive our business and support our customers globally. However, a portion of our employees in Israel have been called to active reserve duty and additional employees may be called in the future, if needed. The Company has executed its business continuity plan with respect to those employees. It is possible that some of our operations in the region may be disrupted if this continues for a significant period of time or if the situation further deteriorates.

RESULTS OF OPERATIONS

Total Revenues

Total revenues were $22.1 million for the first quarter of 2024, representing a decrease of 16% as compared to the corresponding period in 2023. The decrease in total revenues for the first quarter of 2024 was mainly due to lower licensing and related revenues, offset by higher royalty revenues, as further described below.

Our five largest customers accounted for 45% of our total revenues for the first quarter of 2024, as compared to 43% for the comparable period in 2023. Two customers accounted for 15% and 14% of our total revenues for the first quarter of 2024, as compared to one customer that accounted for 14% of our total revenues for the first quarter of 2023. Generally, the identity of our customers representing 10% or more of our total revenues varies from period to period, especially with respect to our IP licensing customers as we generate licensing revenues generally from new customers on a quarterly basis. With respect to our royalty revenues, two royalty paying customers represented 10% or more of our total royalty revenues for the first quarter of 2024, and collectively represented 41% of our total royalty revenues for the first quarter of 2024. Two royalty paying customers represented 10% or more of our total royalty revenues for the first quarter of 2023, and collectively represented 28% of our total royalty revenues for the first quarter of 2023. We expect that a significant portion of our future revenues will continue to be generated by a limited number of customers. The concentration of our customers is explainable in part by consolidation in the semiconductor industry.

The following table sets forth use cases for Ceva technology portfolio as percentages of our total revenues for each of the periods set forth below:

	First quarter 2024			First quarter 2023

Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT)		82	%		82	%
Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI)		18	%		18	%

Licensing and Related Revenues

Licensing and related revenues were $11.4 million for the first quarter of 2024, representing a decrease of 37%, as compared to the corresponding period in 2023. Licensing revenues for the first quarter of 2024 were lower than anticipated, as some deals were delayed into the second quarter and later in the year. We signed strategic early-adopter deals with lead customers for our Bluetooth 6 and Wi-Fi 7 IPs in the quarter and have already concluded a significant deal with a strategic customer for a next-generation IP since the close of the quarter.

Eleven IP license agreements were concluded during the first quarter of 2024, targeting a wide variety of end markets and applications, including Bluetooth 5 connectivity for wearables and industrial IoT, Bluetooth 6 for wireless audio, Wi-Fi 6, Wi-Fi 7 and UWB for smart edge consumer devices, 5G RedCap for consumer and industrial devices, 5G V2X modems for automotive, and audio for smartphones. Two of the eleven deals were with first-time customers.

Licensing and related revenues accounted for 52% of our total revenues for the first quarter of 2024, as compared to 69% for the comparable period of 2023.

Royalty Revenues

Royalty revenues were $10.7 million for the first quarter of 2024, representing an increase of 33%, as compared to the corresponding period in 2023. Royalty revenues accounted for 48% of our total revenues for the first quarter of 2024, as compared to 31% for the comparable period of 2023. The first quarter of 2024 included revenue of $1.0 million following the resolution of a royalty audit. Excluding this amount, the first quarter of 2024 would have been up by 20% as compared to the comparable period of 2023. In the first quarter of 2024 we saw shipment volumes up 25% year-over-year, and increase in every end market we serve, as restocking continued across the broad IoT markets. Smartphone units, while up year-over-year, were down quite sharply from the fourth quarter, a similar trend to what we saw last year. Also, the infrastructure market remains soft, reflecting low CapEx for 5G networks globally.

The increase in royalty revenues for the first quarter of 2024 was mainly due to customer inventory adjustments and prolonged weak demand for smartphones and PCs in the first quarter of 2023.

Table of Contents

Our customers reported sales of 371 million chipsets incorporating our technologies for the first quarter of 2024, an increase of 25% from the corresponding period in 2023 for actual shipments reported.

The five largest royalty-paying customers accounted for 58% of our total royalty revenues for the first quarter of 2024, as compared to 49% for the comparable period of 2023.

Geographic Revenue Analysis

	First quarter 2024				First quarter 2023
	(in millions, except percentages)
United States	$	2.6	11	%	$	2.4	9	%
Europe and Middle East	$	1.5	7	%	$	2.8	11	%
Asia Pacific (1)	$	18.0	82	%	$	20.6	78	%
Other	$	--	--	%	$	0.5	2	%

(1) China	$	13.6	62	%	$	17.8	68	%

Due to the nature of our license agreements and the associated potential large individual contract amounts, the geographic split of revenues both in absolute dollars and percentage terms generally varies from quarter to quarter.

Cost of Revenues

Cost of revenues was $2.5 million for the first quarter of 2024, as compared to $3.5 million for the comparable period of 2023. Cost of revenues accounted for 11% of our total revenues for the first quarter of 2024, as compared to 13% for the comparable period of 2023. The decrease for the first quarter of 2024 principally reflected lower customization work for our licensees and lower cost of unit shipments related to our sensor fusion chip business. Included in cost of revenues for the first quarter of 2024 was a non-cash equity-based compensation expense of $203,000, as compared to $206,000 for the comparable period of 2023.

Gross Margin

Gross margin for the first quarter of 2024 was 89%, as compared to 87% for the comparable period of 2023. The increase for the first quarter of 2024 mainly reflected lower cost of revenues as set forth above, offset by lower total revenues. The gross margin for the first quarter of 2023 reflects historical period on a re-cast basis excluding the Intrisix business as a discontinued operation, is also illustrative of our decision to return to pure IP licensing and royalty business model.

Operating Expenses

Total operating expenses were $24.5 million for the first quarter of 2024, as compared to $25.4 million for the comparable period of 2023. The net decrease for the first quarter of 2024 principally reflected lower contractor costs.

Research and Development Expenses, Net

Our research and development expenses, net, were $18.0 million for the first quarter of 2024, as compared to $18.7 million for the comparable period of 2023. The decrease for the first quarter of 2024 principally reflected lower contractor costs. Included in research and development expenses for the first quarter of 2024 were non-cash equity-based compensation expenses of $2,007,000, as compared to $2,102,000 for the comparable period of 2023. Research and development expenses as a percentage of our total revenues were 82% for the first quarter of 2024, as compared to 71% for the comparable period of 2023. The percentage increase for the first quarter of 2024, as compared to the comparable period of 2023, was mainly due to lower revenues.

The number of research and development personnel was 331 at March 31, 2024, as compared to 337 at March 31, 2023.

Table of Contents

Sales and Marketing Expenses

Our sales and marketing expenses were $2.8 million for the first quarter of 2024, as compared to $2.7 million for the comparable period of 2023. Included in sales and marketing expenses for the first quarter of 2024 were non-cash equity-based compensation expenses of $365,000, as compared to $378,000 for the comparable period of 2023. Sales and marketing expenses as a percentage of our total revenues were 13% for the first quarter of 2024, as compared to 10% for the comparable period of 2023.

The total number of sales and marketing personnel was 28 at March 31, 2024, as compared to 31 at March 31, 2023.

General and Administrative Expenses

Our general and administrative expenses were $3.6 million for the first quarter of 2024, as compared to $3.8 million for the comparable period of 2023. The decrease for the first quarter of 2024 primarily reflected lower salaries and related costs. Included in general and administrative expenses for the first quarter of 2024 were non-cash equity-based compensation expenses of $996,000, as compared to $866,000 for the comparable period of 2023. General and administrative expenses as a percentage of our total revenues were 16% for the first quarter of 2024, as compared to 15% for the comparable period of 2023.

The number of general and administrative personnel was 46 at March 31, 2024, as compared to 41 at March 31, 2023.

Amortization of Intangible Assets

Our amortization charges were $0.2 million for both the first quarter of 2024 and 2023. The amortization charges for the first quarter of 2024 were incurred in connection with the amortization of intangible assets associated with the acquisitions of the Hillcrest Labs and VisiSonics business. The amortization charges for the first quarter of 2023 were incurred in connection with the amortization of intangible assets associated with the acquisitions of the Hillcrest Labs.

Financial Income, Net (in millions)

	First quarter 2024			First quarter 2023
Financial income, net	$	1.26		$	1.45
*of which:*
Interest income and gains and losses from marketable securities, net	$	1.45		$	1.19
Foreign exchange gain (loss)	$	(0.19	)	$	0.26

Financial income, net, consists of interest earned on investments, gains and losses from sale of marketable securities, accretion (amortization) of discounts (premiums) on marketable securities and foreign exchange movements.

The increase in interest income and gains and losses from marketable securities, net, during the first quarter of 2024 principally reflected higher combined bank deposits and marketable securities balances held (mainly because of cash received from the sale of Intrinsix in October 2023) and higher yields.

We review our monthly expected major non-U.S. dollar denominated expenditures and look to hold equivalent non-U.S. dollar cash balances to mitigate currency fluctuations. However, our Euro cash balances increase significantly on a quarterly basis beyond our Euro liabilities, mainly from applicable French research tax credits, which are generally refunded every three years. This has resulted in a foreign exchange loss of $0.19 million for the first quarter of 2024, as compared to foreign exchange gain of $0.26 million for the comparable period of 2023.

Remeasurement of Marketable Equity Securities

We recorded a loss of $0.0 million for the first quarter of 2024, as compared to a loss of $0.1 million for the comparable period of 2023, related to remeasurement of marketable equity securities, which we hold at cost. Over time, other income (expense), net, may be affected by market dynamics and other factors. Equity values generally change daily for marketable equity securities and upon the occurrence of observable price changes or upon impairment of marketable equity securities. In addition, volatility in the global economic climate and financial markets could result in a significant change in the value of our investments.

Table of Contents

Provision for Income Taxes

Our income tax expenses was $1.7 million for the first quarter of 2024, as compared to $1.4 million for the comparable period of 2023. The increase for the first quarter of 2024 primarily reflected higher withholding tax expenses in our Israeli subsidiary for which we will not be able to obtain a refund from the tax authorities.

We are subject to income and other taxes in the United States and in numerous foreign jurisdictions. Our domestic and foreign tax liabilities are dependent on the jurisdictions in which profits are determined to be earned and taxed. Additionally, the amount of taxes paid is subject to our interpretation of applicable tax laws in the jurisdictions in which we operate. A number of factors influence our effective tax rate, including changes in tax laws and treaties as well as the interpretation of existing laws and rules. Federal, state, and local governments and administrative bodies within the United States, and other foreign jurisdictions have implemented, or are considering, a variety of broad tax, trade, and other regulatory reforms that may impact us. For example, the Tax Cuts and Jobs Act (the “U.S. Tax Reform”) enacted on December 22, 2017 resulted in changes in our corporate tax rate, our deferred income taxes, and the taxation of foreign earnings. It is not currently possible to accurately determine the potential comprehensive impact of these or future changes, but these changes could have a material impact on our business and financial condition.

We have significant operations in Israel and operations in France and the Republic of Ireland. A substantial portion of our taxable income is generated in Israel and France, as well as potentially in the U.S. due to global intangible low-taxed income (GILTI) and the requirement to capitalize R&D expenditures under IRC Section 174 over 5 years if sourced from the U.S. and over 15 years if sourced internationally. Although our Israeli and Irish subsidiaries, and, from 2022 onward, our French subsidiary, are taxed at rates substantially lower than U.S. tax rates, the tax rates in these jurisdictions could nevertheless result in a substantial increase as a result of withholding tax expenses with respect to which we are unable to obtain a refund from the relevant tax authorities.

Our Irish subsidiary qualified for a 12.5% tax rate on its trade. Interest income generated by our Irish subsidiary is taxed at a rate of 25%.

Our French subsidiary is entitled to a tax benefit of 10% applied to specific revenues under the French IP Box regime. The French IP Box regime applies to net income derived from the licensing, sublicensing or sale of several IP rights such as patents and copyrighted software, including royalty revenues. This elective regime requires a direct link between the income benefiting from the preferential treatment and the R&D expenditures incurred and contributing to that income. Qualifying income may be taxed at a favorable 10% CIT rate (plus social surtax, hence 10.3% in total).

Our Israeli subsidiary is entitled to various tax benefits as a technological enterprise. In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016, which includes the Amendment to the Law for the Encouragement of Capital Investments, 1959 (Amendment 73) (the “Amendment”), was published. The Amendment, among other things, prescribes special tax tracks for technological enterprises, which are subject to rules that were issued by the Minister of Finance in April 2017.

The new tax track under the Amendment, which is applicable to our Israeli subsidiary, is the “Technological Preferred Enterprise”. Technological Preferred Enterprise is an enterprise for which total consolidated revenues of its parent company and all subsidiaries are less than 10 billion New Israeli Shekel (NIS). A Technological Preferred Enterprise, as defined in the Amendment, that is located in the center of Israel (where our Israeli subsidiary is currently located), is taxed at a rate of 12% on profits deriving from intellectual property. Any dividends distributed to “foreign companies”, as defined in the Amendment, deriving from income from technological enterprises will be taxed at a rate of 4%. We are applying the Technological Preferred Enterprise tax track for our Israeli subsidiary from tax year 2020 and onwards.

Critical Accounting Policies and Estimates

Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates.

Table of Contents

We believe that the assumptions and estimates associated with revenue recognition, fair value of financial instruments, equity-based compensation and income taxes have the greatest potential impact on our consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates.

See our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 7, 2024, for a discussion of additional critical accounting policies and estimates. There have been no changes in our critical accounting policies as compared to what was previously disclosed in the Annual Report on Form 10-K for the year ended December 31, 2023.

LIQUIDITY AND CAPITAL RESOURCES

As of March 31, 2024, we had approximately $21.2 million in cash and cash equivalents, $10.7 million in bank deposits, and $126.9 million in marketable securities, totaling $158.8 million, as compared to $166.5 million at December 31, 2023. The decrease for the first three months of 2024 principally reflected cash used in operating activities.

Out of total cash, cash equivalents, bank deposits and marketable securities of $158.8 million, $129.7 million was held by our foreign subsidiaries. Our intent is to permanently reinvest earnings of our foreign subsidiaries and our current operating plans do not demonstrate a need to repatriate foreign earnings to fund our U.S. operations. However, if these funds were needed for our operations in the United States, we would be required to accrue and pay taxes to repatriate these funds. The determination of the amount of additional taxes related to the repatriation of these earnings is not practicable, as it may vary based on various factors such as the location of the cash and the effect of regulation in the various jurisdictions from which the cash would be repatriated.

During the first three months of 2024, we invested $12.7 million of cash in marketable securities with maturities up to 36 months from the balance sheet date. In addition, during the same period, marketable securities were sold or redeemed for cash amounting to $18.9 million. All of our marketable securities are classified as available-for-sale. The purchase and sale or redemption of available-for-sale marketable securities are considered part of investing cash flow. Available-for-sale marketable securities are stated at fair value, with unrealized gains and losses reported in accumulated other comprehensive income (loss), a separate component of stockholders’ equity, net of taxes. Realized gains and losses on sales of investments, as determined on a specific identification basis, are included in the interim condensed consolidated statements of loss. The amount of credit losses recorded for the first three months of 2024 was immaterial. For more information about our marketable securities, see Note 7 to the interim condensed consolidated financial statements for the three months ended March 31, 2024.

Bank deposits are classified as short-term bank deposits and long-term bank deposits. Short-term bank deposits are deposits with maturities of more than three months but no longer than one year from the balance sheet date, whereas long-term bank deposits are deposits with maturities of more than one year as of the balance sheet date. Bank deposits are presented at their cost, including accrued interest, and purchases and sales are considered part of cash flows from investing activities.

Operating Activities

Cash used in operating activities for the first three months of 2024 was $7.3 million and consisted of net loss of $5.4 million, adjustments for non-cash items of $4.6 million, and changes in operating assets and liabilities of $6.5 million. Adjustments for non-cash items primarily consisted of $1.0 million of depreciation and amortization of intangible assets, and $3.6 million of equity-based compensation expenses. The decrease in operating assets and liabilities primarily consisted of an increase in trade receivables of $3.0 million, an increase in prepaid expenses and other assets of $3.2 million (mainly as a result of payment of a yearly design tool subscription), a decrease in deferred revenues of $0.5 million, and a decrease in accrued expenses and other payables of $1.0 million, partially offset by an increase in accrued payroll and related benefits of $0.5 million and an increase in trade payables of $0.4 million.

Cash used in operating activities for the first three months of 2023 was $5.1 million and consisted of net loss of $4.9 million, adjustments for non-cash items of $5.0 million, and changes in operating assets and liabilities of $5.2 million. Adjustments for non-cash items primarily consisted of $1.4 million of depreciation and amortization of intangible assets, and $3.9 million of equity-based compensation expenses, offset with $0.3 million of unrealized foreign exchange gain. The decrease in operating assets and liabilities primarily consisted of an increase in trade receivables of $3.8 million, an increase in prepaid expenses and other assets of $2.2 million (mainly as a result of payment of a yearly design tool subscription), and an increase in deferred taxes, net of $0.9 million, partially offset by an increase in deferred revenues of $0.8 million, and an increase in accrued payroll and related benefits of $0.7 million.

Cash flows from operating activities may vary significantly from quarter to quarter depending on the timing of our receipts and payments. Our ongoing cash outflows from operating activities principally relate to payroll-related costs and obligations under our property leases and design tool licenses. Our primary sources of cash inflows are receipts from our accounts receivable, to some extent, funding from research and development government grants and French research tax credits, and interest earned from our cash, deposits and marketable securities. The timing of receipts of accounts receivable from customers is based upon the completion of agreed milestones or agreed dates as set out in the contracts.

Table of Contents

Investing Activities

Net cash provided by investing activities for the first three months of 2024 was $5.1 million, compared to $6.5 million of net cash provided by investing activities for the comparable period of 2023. We had a cash outflow of $12.7 million and a cash inflow of $18.9 million with respect to investments in marketable securities during the three months of 2024, as compared to a cash inflow of $6.6 million with respect to investments in marketable securities during the first three months of 2023. We had a cash outflow of $0.9 million and $0.1 million during the first three months of 2024 and 2023, respectively, from purchase of property and equipment. For the first three months of 2024, we had a cash inflow of $0.5 million in connection with the sale of Intrinsix, and a cash outflow of $0.8 million for the acquisition of the Greek-based company.

Financing Activities

Net cash provided by financing activities for the first three months of 2024 was $0.3 million, as compared to $1.7 million of net cash provided by financing activities for the comparable period of 2023.

In August 2008, we announced that our board of directors approved a share repurchase program for up to one million shares of common stock pursuant to Rule 10b-18 of the Exchange Act, which was extended by an additional 7,100,000 shares collectively across further approvals in 2010, 2013, 2014, 2018, 2020 and 2023. During the first three months ended March 31, 2024, we repurchased 56,872 shares of common stock at an average purchase price of $22.48 per share for an aggregate purchase price of $1,278. There were no repurchases of our common stock during the three months ended March 31, 2023. As of March 31, 2024, we had 643,128 shares available for repurchase.

During the first three months of 2024, we received $1.6 million from the exercise of stock-based awards, as compared to $1.7 million received for the comparable period of 2023.

We believe that our cash and cash equivalents, short-term bank deposits and marketable securities, along with cash from operations, will provide sufficient capital to fund our operations for at least the next 12 months. We cannot provide assurances, however, that the underlying assumed levels of revenues and expenses will prove to be accurate.

In addition, as part of our business strategy, we occasionally evaluate potential acquisitions of businesses, products and technologies and minority equity investments. Accordingly, a portion of our available cash may be used at any time for the acquisition of complementary products or businesses or minority equity investments. Such potential transactions may require substantial capital resources, which may require us to seek additional debt or equity financing. We cannot assure you that we will be able to successfully identify suitable acquisition or investment candidates, complete acquisitions or investments, integrate acquired businesses into our current operations, or expand into new markets. Furthermore, we cannot provide assurances that additional financing will be available to us in any required time frame and on commercially reasonable terms, if at all.

Item 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

A majority of our revenues and a portion of our expenses are transacted in U.S. dollars and our assets and liabilities together with our cash holdings are predominately denominated in U.S. dollars. However, the majority of our expenses are denominated in currencies other than the U.S. dollar, principally the NIS and the Euro. Increases in volatility of the exchange rates of currencies other than the U.S. dollar versus the U.S. dollar could have an adverse effect on the expenses and liabilities that we incur when remeasured into U.S. dollars. We review our monthly expected non-U.S. dollar denominated expenditures and look to hold equivalent non-U.S. dollar cash balances to mitigate currency fluctuations. However, our Euro cash balances increase significantly on a quarterly basis beyond our Euro liabilities, mainly from French research tax benefits applicable to the CIR, which is generally refunded every three years. This has resulted in a foreign exchange loss of $193,000 for the first quarter of 2024, and a foreign exchange gain of $263,000 for the comparable period of 2023.

As a result of currency fluctuations and the remeasurement of non-U.S. dollar denominated expenditures to U.S. dollars for financial reporting purposes, we may experience fluctuations in our operating results on an annual and quarterly basis. To protect against the increase in value of forecasted foreign currency cash flow resulting from salaries paid in currencies other than the U.S. dollar during the year, we follow a foreign currency cash flow hedging program. We hedge portions of the anticipated payroll for our non-U.S. employees denominated in currencies other than the U.S. dollar for a period of one to twelve months with forward and option contracts. During the first quarter of 2024 and 2023, we recorded accumulated other comprehensive loss of $575,000 and $253,000, respectively, from our forward and option contracts, net of taxes, with respect to anticipated payroll expenses for our non-U.S. employees. As of March 31, 2024, the amount of other comprehensive gain from our forward and option contracts, net of taxes, was $413,000, which will be recorded in the consolidated statements of income (loss) during the following four months. We recognized a net gain of $380,000 and a net loss of $171,000 for the first quarter of 2024 and 2023, respectively, related to forward and options contracts. We note that hedging transactions may not successfully mitigate losses caused by currency fluctuations. We expect to continue to experience the effect of exchange rate and currency fluctuations on an annual and quarterly basis.

Table of Contents

The majority of our cash and cash equivalents are invested in high-grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits may be redeemed and therefore minimal credit risk exists with respect to them. Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation (FDIC) insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. While we monitor on a systematic basis the cash and cash equivalent balances in the operating accounts and adjust the balances as appropriate, these balances could be impacted if one or more of the financial institutions with which we deposit our funds fails or is subject to other adverse conditions in the financial or credit markets. To date, we have experienced no loss of principal or lack of access to our invested cash or cash equivalents; however, we can provide no assurance that access to our invested cash and cash equivalents will not be affected if the financial institutions that we hold our cash and cash equivalents fail.

We hold an investment portfolio consisting principally of corporate bonds. We have the ability to hold such investments until recovery of temporary declines in market value or maturity. As of March 31, 2024, the unrealized losses associated with our investments were approximately $3.5 million due to the dramatic changes in the interest rate environment that took place in 2022. As we tend to hold such bonds with unrealized losses to recovery, the allowance for credit losses was not material during the first quarter of 2024. However, we can provide no assurance that we will recover present declines in the market value of our investments.

Interest income and gains and losses from marketable securities, net, were $1.45 million for the first quarter of 2024, as compared to $1.19 million for the comparable period of 2023. The increase in interest income, and gains and losses from marketable securities, net, during the first quarter of 2024, reflected higher combined bank deposits and marketable securities balances held (mainly because of cash received from the sale of Intrinsix in October 2023) and higher yields.

We are exposed primarily to fluctuations in the level of U.S. interest rates. To the extent that interest rates rise, fixed interest investments may be adversely impacted, whereas a decline in interest rates may decrease the anticipated interest income for variable rate investments. We typically do not attempt to reduce or eliminate our market exposures on our investment securities because the majority of our investments are short-term. We currently do not have any derivative instruments but may put them in place in the future. Fluctuations in interest rates within our investment portfolio have not had, and we do not currently anticipate such fluctuations will have, a material effect on our financial position on an annual or quarterly basis.

Item 4.

CONTROLS AND PROCEDURES

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2024.

There has been no change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

PART II OTHER INFORMATION

Item 1

LEGAL PROCEEDINGS

We are not a party to any litigation or other legal proceedings that we believe could reasonably be expected to have a material effect on our business, results of operations and financial condition.

Item 1A

RISK FACTORS

We have not identified any material changes to the Risk Factors previously disclosed in Part I—Item IA—“Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, any one or more of which could, directly or indirectly, cause our actual financial condition and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any of those factors, in whole or in part, could materially and adversely affect our business, financial condition, operating results and stock price. You should carefully consider the risks and uncertainties described in our Annual Report filed on Form 10-K for the fiscal year ended December 31, 2023, together with all of the other information in this Quarterly Report on Form 10-Q, including in “Part I—Item 2—”Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the condensed consolidated financial statements and related notes.

Table of Contents

Item 2

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The table below sets forth the information with respect to repurchases of our common stock during the three months ended March 31, 2024.

Period	(a) Total Number of Shares Purchased		(b) Average Price Paid per Share		(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		(d) Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (1)
Month #1 (January 1, 2024 to January 31, 2024)	—		—		—			700,000
Month #2 (February 1, 2024 to February 29, 2024)		40,102	$	22.36		40,102		659,898
Month #3 (March 1, 2024 to March 31, 2024)		16,770	$	22.75		16,770		643,128
TOTAL		56,872	$	22.48		56,872		643,128	(2)

(1)

(2)

The number represents the number of shares of our common stock that remain available for repurchase pursuant to our share repurchase program.

Item 3

DEFAULTS UPON SENIOR SECURITIES

Not applicable.

Item 4

MINE SAFETY DISCLOSURES

Not applicable.

Item 5

OTHER INFORMATION

During the three months ended March 31, 2024, no director or officer (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

Table of Contents

Item 6

EXHIBITS

Exhibit No.	Description
10.1*†	2024 Incentive Plan for Gweltaz Toquet, Chief Commercial Officer (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on February 16, 2024).
31.1	Rule 13a14(a)/15d14(a) Certification of Chief Executive Officer.
31.2	Rule 13a14(a)/15d14(a) Certification of Chief Financial Officer.
32	Section 1350 Certification of Chief Executive Officer and Chief Financial Officer.

101	The following materials from CEVA, Inc.’s Quarterly report on Form 10-Q for the quarter ended September 30, 2023, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Statements of Loss, (ii) the Condensed Consolidated Balance Sheet, (iii) the Condensed Consolidated Statements of Cash Flows, (iv) the Condensed Consolidated Statements of Comprehensive Loss, (v) Condensed Consolidated Statements of Changes in Stockholders’ Equity, and (vi) Notes to Condensed Consolidated Financial Statements.

104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

* Portions of exhibit are redacted.

† Indicates management compensatory plan or arrangement.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	CEVA, INC.

Date: May 9, 2024	By: /s/ AMIR PANUSH
	Amir Panush Chief Executive Officer (principal executive officer)

Date: May 9, 2024	By: /s/ YANIV ARIELI
	Yaniv Arieli Chief Financial Officer (principal financial officer and principal accounting officer)

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

I, Amir Panush, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of CEVA, Inc. (the “Company”);

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a15(e) and 15d15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a15(f) and 15d15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2024

/s/ AMIR PANUSH

Amir Panush

Chief Executive Officer

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

I, Yaniv Arieli, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of CEVA, Inc. (the “Company”);

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a15(e) and 15d15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a15(f) and 15d15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2024

/s/ YANIV ARIELI

Yaniv Arieli

Chief Financial Officer

Exhibit 32

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of CEVA, Inc. (the “Company”) for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Amir Panush, Chief Executive Officer of the Company, and Yaniv Arieli, Chief Financial Officer of the Company, each hereby certifies, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.

Date: May 9, 2024
	/s/ AMIR PANUSH
	Amir Panush
	Chief Executive Officer


	/s/ YANIV ARIELI
	Yaniv Arieli
	Chief Financial Officer

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Mar. 31, 2024	May 06, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	000-49842
Entity Registrant Name	CEVA, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0556376
Entity Address, Address Line One	15245 Shady Grove Road, Suite 400
Entity Address, City or Town	Rockville
Entity Address, State or Province	MD
Entity Address, Postal Zip Code	20850
City Area Code	240
Local Phone Number	308-8328
Title of 12(b) Security	Common Stock, $.001 per share
Trading Symbol	CEVA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		23,582,142
Entity Central Index Key	0001173489
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false

Interim Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 21,222	$ 23,287
Short-term bank deposits	10,662	10,556
Marketable securities	126,870	132,695
Trade receivables (net of allowance for credit losses of $288 at both March 31, 2024 and December 31, 2023)	33,635	30,307
Prepaid expenses and other current assets	13,378	12,526
Total current assets	205,767	209,371
Long-term assets:
Severance pay fund	6,897	7,070
Deferred tax assets, net	1,239	1,609
Property and equipment, net	7,157	6,732
Operating lease right-of-use assets	6,704	6,978
Goodwill	58,308	58,308
Intangible assets, net	2,689	2,967
Investments in marketable equity securities	346	406
Other long-term assets	12,332	10,644
Total long-term assets	95,672	94,714
Total assets	301,439	304,085
Current liabilities:
Trade payables	1,804	1,154
Deferred revenues	2,479	3,018
Accrued expenses and other payables	4,984	5,800
Accrued payroll and related benefits	14,854	14,402
Operating lease liabilities	2,634	2,513
Total current liabilities	26,755	26,887
Long-term liabilities:
Accrued severance pay	7,339	7,524
Operating lease liabilities	3,525	3,943
Other accrued liabilities	1,471	1,390
Total long-term liabilities	12,335	12,857
Stockholders’ equity:
Preferred Stock: $0.001 par value: 5,000,000 shares authorized; none issued and outstanding	0	0
Common Stock: $0.001 par value: 45,000,000 shares authorized; 23,695,190 shares issued at March 31, 2024 and December 31, 2023. 23,581,522 and 23,440,848 shares outstanding at March 31, 2024 and December 31, 2023, respectively	24	23
Additional paid in-capital	252,927	252,100
Treasury stock at cost (113,668 and 254,342 shares of common stock at March 31, 2024, and December 31, 2023, respectively)	(2,528)	(5,620)
Accumulated other comprehensive loss	(2,720)	(2,329)
Accumulated Other Comprehensive Income (Loss), Net of Tax	(2,720)	(2,329)
Retained earnings	14,646	20,167
Total stockholders’ equity	262,349	264,341
Total liabilities and stockholders’ equity	$ 301,439	$ 304,085

Interim Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accounts Receivable, Allowance for Credit Loss	$ 288	$ 288
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized (in shares)	5,000,000	5,000,000
Preferred Stock, Shares Issued (in shares)	0	0
Preferred Stock, Shares Outstanding (in shares)	0	0
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.001	$ 0.001
Common Stock, Shares Authorized (in shares)	45,000,000	45,000,000
Common Stock, Shares, Issued (in shares)	23,695,190	23,695,190
Common Stock, Shares, Outstanding (in shares)	23,581,522	23,440,848
Treasury Stock, Common, Shares (in shares)	113,668	254,342

Interim Condensed Consolidated Statements of Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
us-gaap_RevenuesAbstract
Revenue	$ 22,072	$ 26,262
Cost of revenues	2,503	3,508
Gross profit	19,569	22,754
Operating expenses:
Research and development, net	17,991	18,674
Sales and marketing	2,816	2,719
General and administrative	3,572	3,827
Amortization of intangible assets	150	154
Total operating expenses	24,529	25,374
Operating income (loss)	(4,960)	(2,620)
Financial income, net	1,257	1,455
Remeasurement of marketable equity securities	(60)	(117)
Loss before taxes on income	(3,763)	(1,282)
Income tax expense	1,685	1,417
Net loss	(5,448)	(2,699)
Net loss from discontinued operation	0	(2,173)
Net loss	$ (5,448)	$ (4,872)
Basic and diluted (in dollars per share)	$ (0.23)	$ (0.12)
Basic and diluted net loss per share from discontinued operation (in dollars per share)	0	(0.09)
Basic and diluted net loss per share (in dollars per share)	$ (0.23)	$ (0.21)
us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract
Basic and diluted (in shares)	23,508	23,334
License [Member]
us-gaap_RevenuesAbstract
Revenue	$ 11,414	$ 18,248
Royalty [Member]
us-gaap_RevenuesAbstract
Revenue	$ 10,658	$ 8,014

Interim Condensed Consolidated Statements of Comprehensive (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net loss:	$ (5,448)	$ (4,872)
Available-for-sale securities:
Changes in unrealized losses	200	730
Reclassification adjustments for (gains) losses included in net loss	(4)	(92)
Net change	196	638
Cash flow hedges:
Changes in unrealized gains (losses)	(195)	(425)
Reclassification adjustments for losses included in net loss	(380)	171
Net change	(575)	(254)
Other comprehensive income (loss) before tax	(379)	384
Income tax expense (benefit) related to components of other comprehensive income (loss)	12	45
Other comprehensive income (loss), net of taxes	(391)	339
Comprehensive loss	$ (5,839)	$ (4,533)

Interim Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock Outstanding [Member]	Additional Paid-in Capital [Member]	Treasury Stock, Common [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2022	23,215,439
Balance at Dec. 31, 2022	$ 23	$ 242,841	$ (9,904)	$ (6,249)	$ 32,160	$ 258,871
Net loss	0	0	0	0	(4,872)	(4,872)
Other comprehensive income	0	0	0	339	0	339
Equity-based compensation	$ 0	3,859	0	0	0	$ 3,859
Issuance of treasury stock upon exercise of stock-based awards (in shares)						0
Issuance of treasury stock upon exercise of stock-based awards (in shares)	200,587
Issuance of treasury stock upon exercise of stock-based awards	$ 0	(3,559)	5,232	0	0	$ 1,673
Balance (in shares) at Mar. 31, 2023	23,416,026
Balance at Mar. 31, 2023	$ 23	243,141	(4,672)	(5,910)	27,288	259,870
Balance (in shares) at Dec. 31, 2023	23,440,848
Balance at Dec. 31, 2023	$ 23	252,100	(5,620)	(2,329)	20,167	264,341
Net loss	0	0	0	0	(5,448)	(5,448)
Other comprehensive income	0	0	0	(391)	0	(391)
Equity-based compensation	$ 0	3,571	0	0	0	$ 3,571
Issuance of treasury stock upon exercise of stock-based awards (in shares)	(56,872)					56,872
Issuance of treasury stock upon exercise of stock-based awards	$ 0	0	1,278	0	0	$ 1,278
Issuance of treasury stock upon exercise of stock-based awards (in shares)	197,546
Issuance of treasury stock upon exercise of stock-based awards	$ 1	(2,744)	4,370	0	(73)	1,554
Balance (in shares) at Mar. 31, 2024	23,581,522
Balance at Mar. 31, 2024	$ 24	$ 252,927	$ (2,528)	$ (2,720)	$ 14,646	$ 262,349

Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss:	$ (5,448)	$ (4,872)
Adjustments required to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation	700	742
Amortization of intangible assets	278	677
Equity-based compensation	3,571	3,859
Realized loss (gain) on sale of available-for-sale marketable securities	(4)	(92)
Amortization of premiums on available-for-sale marketable securities	(191)	(23)
Amortization of premiums on available-for-sale marketable securities	191	23
Unrealized foreign exchange loss (gain)	165	(285)
Remeasurement of marketable equity securities	60	117
Changes in operating assets and liabilities:
Trade receivables	(3,003)	(3,802)
Prepaid expenses and other assets	(3,194)	(2,205)
Operating lease right-of-use assets	274	249
Accrued interest on bank deposits	(106)	(125)
Deferred tax, net	358	(880)
Trade payables	433	(412)
Deferred revenues	(539)	838
Accrued expenses and other payables	(973)	357
Accrued payroll and related benefits	510	702
Operating lease liability	(235)	(275)
Accrued severance pay, net	(6)	308
Net cash used in operating activities	(7,350)	(5,076)
Cash flows from investing activities:
Purchase of property and equipment	904	105
Proceeds from the sale of Intrinsix (see note 4)	540	0
Acquisition of business	(753)	0
Investment in available-for-sale marketable securities	(12,653)	0
Proceeds from maturity of available-for-sale marketable securities	14,080	1,750
Proceeds from maturity of available-for-sale marketable securities	4,789	4,895
Net cash provided by (used in) investing activities	5,099	6,540
Cash flows from financing activities:
Purchase of treasury stock	(1,278)	0
Proceeds from exercise of stock-based awards	1,554	1,673
Net cash provided by (used in) financing activities	276	1,673
Effect of exchange rate changes on cash and cash equivalents	(90)	61
Increase (decrease) in cash and cash equivalents	(2,065)	3,198
Cash and cash equivalents at the beginning of the period	23,287	21,285
Cash and cash equivalents at the end of the period	21,222	24,483
Supplemental information of cash-flow activities:
Income and withholding taxes	873	1,860
Non-cash transactions:
Property and equipment purchases incurred but unpaid at period end	200	234
Right-of-use assets obtained in the exchange for operating lease liabilities	303	506
Cash and cash equivalents	21,222	24,209
Cash and cash equivalents included in assets of discontinued operation	0	274
Total cash and cash equivalents in the Condensed Consolidated Statements of Cash Flows	$ 21,222	$ 24,483

Note 1 - Business

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Nature of Operations [Text Block]

NOTE 1:

BUSINESS

The financial information in this quarterly report includes the results of Ceva, Inc. and its subsidiaries (the “Company” or “Ceva”).

Note 2 - Basis of Presentation and Summary Significant Accounting Policies

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]

NOTE 2:

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The interim condensed consolidated financial statements have been prepared according to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).

Accounting Standards Recently Adopted by the Company

Accounting Standards Recently Issued, Not Yet Adopted by the Company

(in thousands, except share data)

Use of Estimates

Note 3 - Acquisition

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Business Combination Disclosure [Text Block]

NOTE 3:

ACQUISITION

Note 4 - Held for Sale and Discontinued Operation

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

NOTE 4:

HELD FOR SALE AND DISCONTINUED OPERATION

The following table shows the Company's results of discontinued operation for the below presented period:

	Three months ended March 31, 2023 (unaudited)
Revenues	$	2,473
Cost of revenue		1,807
Gross profit		666
Operating expenses:
Research and development, net		2,117
Sales and marketing		326
General and administrative		221
Amortization of intangible assets		175
Total operating expenses		2,839
Operating loss		(2,173	)
Financial income, net		—
Loss from discontinued operations before taxes on income		(2,173	)
Income tax expense		—
Net loss from discontinued operation	$	(2,173	)

The following table presents cash flows from discontinued operations:

Three months

ended March

31, 2023

(unaudited)

Net cash flows used in operating activities (*)

(1,230

)

(*) Amortization and depreciation allocated to discontinued operation for the three-month period ended March 31, 2023 amounted to $492.

Note 5 - Revenue Recognition

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

NOTE 5:

REVENUE RECOGNITION

Remainder

of 2024

2025

2026 and

thereafter

Licensing and related revenues

4,028

1,015

322

Disaggregation of revenue:

The following table provides information about disaggregated revenue by primary geographical, use cases for the Company's technology portfolio, and timing of revenue recognition:

	Three months ended March 31, 2024 (unaudited)						Three months ended March 31, 2023 (unaudited)
	Licensing and related revenues		Royalties		Total		Licensing and related revenues		Royalties		Total
Geography
United States	$	383	$	2,155	$	2,538	$	702	$	1,650	$	2,352
Europe and Middle East		601		911		1,512		1,950		859		2,809
Asia Pacific		10,417		7,592		18,009		15,121		5,505		20,626
Other		13		—		13		475		—		475
Total	$	11,414	$	10,658	$	22,072	$	18,248	$	8,014	$	26,262

Use cases for the Company’s technology portfolio
Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT)	$	10,067	$	7,939	$	18,006	$	15,924	$	5,665	$	21,589
Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI)		1,347		2,719		4,066		2,324		2,349		4,673
Total	$	11,414	$	10,658	$	22,072	$	18,248	$	8,014	$	26,262

Timing of revenue recognition
Products transferred at a point in time	$	9,453	$	10,658	$	20,111	$	14,621	$	8,014	$	22,635
Products and services transferred over time		1,961		—		1,961		3,627		—		3,627
Total	$	11,414	$	10,658	$	22,072	$	18,248	$	8,014	$	26,262

Contract balances:

The following table provides information about trade receivables, unbilled receivables and contract liabilities from contracts with customers:

	March 31, 2024		December 31, 2023

Trade receivables	$	14,052	$	8,433
Unbilled receivables (associated with licensing and related revenue)		9,600		9,735
Unbilled receivables (associated with royalties)		9,983		12,139
Deferred revenues (short-term contract liabilities)		2,479		3,018

During the three months ended March 31, 2024, the Company recognized $1,179 that was included in deferred revenues (short-term contract liability) balance at January 1, 2024.

Note 5 - Leases

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Lessee, Operating Leases [Text Block]

NOTE 6:

LEASES

The following is a summary of weighted average remaining lease terms and discount rates for all of the Company’s operating leases:

March 31, 2024

(Unaudited)

Weighted average remaining lease term (years)

3.97

Weighted average discount rates

4.00

Total operating lease cost and cash payments for operating leases were as follows:

	Three months ended March 31,
	2024		2023
	(unaudited)		(unaudited)

Operating lease cost	$	663	$	753
Cash payments for operating leases		622		727

Maturities of lease liabilities are as follows:

The remainder of 2024	$2,082
2025		2,027
2026		880
2027		640
2028		332
2029 and thereafter		621
Total undiscounted cash flows		6,582
Less imputed interest		423
Present value of lease liabilities	$	6,159

Note 7 - Marketable Securities

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Cash, Cash Equivalents, and Marketable Securities [Text Block]

NOTE 7:

MARKETABLE SECURITIES

The following is a summary of available-for-sale marketable securities:

	March 31, 2024 (Unaudited)
	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Available-for-sale - matures within one year:
Corporate bonds	$	49,434	$	45	$	(743	)	$	48,736

Available-for-sale - matures after one year through three years:
Corporate bonds		80,935		127		(2,928	)		78,134
Total
	$	130,369	$	172	$	(3,671	)	$	126,870

	December 31, 2023
	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Available-for-sale - matures within one year:
Corporate bonds	$	27,690	$	4	$	(243	)	$	27,451

Available-for-sale - matures after one year through three years:
Corporate bonds		108,700		278		(3,734	)		105,244

Total	$	136,390	$	282	$	(3,977	)	$	132,695

	Less than 12 months					12 months or greater
	Fair value		Gross unrealized loss			Fair value		Gross unrealized loss
As of March 31, 2024 (unaudited)	$	23,123	$	(147	)	$	76,036	$	(3,524	)
As of December 31, 2023	$	18,193	$	(49	)	$	86,643	$	(3,928	)

As of March 31, 2024, the allowance for credit losses was not material.

The following table presents gross realized gains and losses from sale of available-for-sale marketable securities:

	Three months ended March 31,
	2024			2023
	(unaudited)			(unaudited)

Gross realized gains from sale of available-for-sale marketable securities	$	9		$	92
Gross realized losses from sale of available-for-sale marketable securities	$	(5	)	$	—

Note 8 - Fair Value Measurement

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Fair Value Disclosures [Text Block]

NOTE 8:

FAIR VALUE MEASUREMENT

Level I	Unadjusted quoted prices in active markets that are accessible on the measurement date for identical, unrestricted assets or liabilities;
Level II	Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
Level III	Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

Description	March 31, 2024 (unaudited)		Level I (unaudited)		Level II (unaudited)		Level III (unaudited)
Assets:
Marketable securities:
Corporate bonds	$	126,870		—	$	126,870		—
Foreign exchange contracts		413		—		413		—
Investments in marketable equity securities		346		346		—		—

Description	December 31, 2023		Level I		Level II		Level III
Assets:
Marketable securities:
Corporate bonds	$	132,695		—	$	132,695		—
Foreign exchange contracts		988		—		988		—
Investments in marketable equity securities		406		406		—		—

Note 9 - Geographic Information and Major Customer Data

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

NOTE 9:

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA

Summary information about geographic areas:

	Three months ended March 31,
	2024 (unaudited)		2023 (unaudited)
Revenues based on customer location:
United States	$	2,538	$	2,352
Europe and Middle East		1,512		2,809
Asia Pacific (1)		18,009		20,626
Other		13		475
	$	22,072	$	26,262

(1) China	$	13,592	$	17,763

Major customer data as a percentage of total revenues:

The following table sets forth the customers that represented 10% or more of the Company’s total revenues in each of the periods set forth below.

	Three months ended March 31,
	2024 (unaudited)			2023 (unaudited)

Customer A		15	%			*)
Customer B		14	%			*)
Customer C			*)		14	*)

*) Less than 10%

Note 10 - Net Loss Per Share of Common Stock

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Earnings Per Share [Text Block]

NOTE 10:

NET LOSS PER SHARE OF COMMON STOCK

	Three months ended March 31,
	2024 (unaudited)			2023 (unaudited)
Numerator:
Net loss from continuing operation	$	(5,448	)	$	(2,699	)
Net loss from discontinued operation		—			(2,173	)
Net loss	$	(5,448	)	$	(4,872	)
Denominator (in thousands):
Basic and diluted weighted-average common stock outstanding		23,508			23,334

Basic and diluted net loss per share from continuing operation	$	(0.23	)	$	(0.12	)
Basic and diluted net loss per share from discontinued operation	$	—		$	(0.09	)
Basic and diluted net loss per share	$	(0.23	)	$	(0.21	)

Note 11 - Common Stock and Stock-based Compensation Plans

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Share-Based Payment Arrangement [Text Block]

NOTE 11:

COMMON STOCK AND STOCK-BASED COMPENSATION PLANS

	Number of options			Weighted average exercise price		Weighted average remaining contractual term		Aggregate intrinsic value
Outstanding as of December 31, 2023		99,425		$	20.74		2.5	$	316
Granted		—			—
Exercised		(13,000	)		14.77
Forfeited or expired		—			—
Outstanding as of March 31, 2024 (unaudited)		86,425		$	21.64		2.6	$	213
Exercisable as of March 31, 2024 (unaudited)		67,000		$	21.64		1.5	$	192

As of March 31, 2024, there was $184 of unrecognized compensation expense related to unvested stock options. This amount is expected to be recognized over a weighted-average period of 2.2 years.

Weighting	Goals
50% (*)	Vesting of the full 50% of the PSUs occurs if the Company achieves the 2024 license and related revenue target approved by the Board (the “2024 License Revenue Target”). The vesting threshold is achievement of 90% of the 2024 License Revenue Target. If the Company’s achievement of the 2024 License Revenue Target is above 90% but less than 99% of the 2024 License Revenue Target, 91% to 99% of the eligible PSUs would be subject to vesting. If the Company’s actual result exceeds 100% of the 2024 License Revenue Target, every 1% increase of the 2024 License Revenue Target, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO.
25%	Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2024 is greater than the S&P Semiconductors Select Industry index (the “S&P index”). The vesting threshold is if the return on the Company’s stock for 2024 is at least 90% of the S&P index. If the return on the Company’s stock, in comparison to the S&P index, is above 90% but less than 99% of the S&P index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company’s stock exceeds 100% of the S&P index, every 1% increase in comparison to the S&P index, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO.
25%	Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2024 is greater than the Russell 2000 index (the “Russell index”). The vesting threshold is if the return on the Company’s stock for 2024 is at least 90% of the Russell index. If the return on the Company’s stock, in comparison to the Russell index, is above 90% but less than 99% of the Russell index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company’s stock exceeds 100% of the Russell index, every 1% increase in comparison to the Russell index, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO.

(*) As of March 31, 2024, the Company's management estimates that it is not probable that the performance condition will be met by year end.

Subject to achievement of the thresholds the above performance goals for 2024, the PSUs vest 33.4% on February 16, 2025, 33.3% on February 16, 2026 and 33.3% on February 16, 2027.

A summary of the Company’s RSU and PSU activities and related information for the three months ended March 31, 2024, are as follows:

	Number of RSUs and PSUs			Weighted Average Grant- Date Fair Value
Unvested as of December 31, 2023		1,281,751		$	24.97
Granted		414,572			17.21
Vested		(112,076	)		36.71
Forfeited or expired		(110,218	)		19.07
Unvested as of March 31, 2024 (unaudited)		1,474,029		$	22.34

As of March 31, 2024, there was $22,830 of unrecognized compensation expense related to unvested RSUs and PSUs. This amount is expected to be recognized over a weighted-average period of 1.6 years.

The following table shows the total equity-based compensation expense included in the interim condensed consolidated statements of loss:

	Three months ended March 31,
	2024 (unaudited)		2023 (unaudited)
Cost of revenue	$	203	$	206
Research and development, net		2,007		2,102
Sales and marketing		365		378
General and administrative		996		866
Total equity-based compensation expense from continuing operations		3,571		3,552
Equity-based compensation expense included in discontinued operations		—		307
Total equity-based compensation expense	$	3,571	$	3,859

The fair value for rights to purchase shares of common stock under the Company’s employee stock purchase plan was estimated on the date of grant using the following assumptions:

	Three months ended March 31
	2024 (unaudited)			2023 (unaudited)
Expected dividend yield		0	%		0	%
Expected volatility		46	%		45	%
Risk-free interest rate		5.3	%		4.8	%
Contractual term of up to (months)		6			6

Note 12 - Derivatives and Hedging Activities

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Derivative Instruments and Hedging Activities Disclosure [Text Block]

NOTE 12:

DERIVATIVES AND HEDGING ACTIVITIES

The fair value of the Company’s outstanding derivative instruments is as follows:

	March 31, 2024		December 31, 2023
Derivative assets:
Derivatives designated as cash flow hedging instruments:
Foreign exchange forward contracts	$	413	$	988
Total	$	413	$	988

The increase (decrease) in unrealized gains (losses) recognized in “accumulated other comprehensive gain (loss)” on derivatives, before tax effect, is as follows:

	Three months ended March 31,
	2024 (unaudited)			2023 (unaudited)
Derivatives designated as cash flow hedging instruments:
Foreign exchange option contracts	$	—		$	(105	)
Foreign exchange forward contracts		(195	)		(320	)
	$	(195	)	$	(425	)

The net (gains) losses reclassified from “accumulated other comprehensive gain (loss)” into income are as follows:

	Three months ended March 31,
	2024 (unaudited)			2023 (unaudited)
Derivatives designated as cash flow hedging instruments:
Foreign exchange option contracts	$	—		$	—
Foreign exchange forward contracts		(380	)		171
	$	(380	)	$	171

Note 13 - Accumulated Other Comprehensive Income (Loss)

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Comprehensive Income (Loss) Note [Text Block]

NOTE 13:

ACCUMULATED OTHER COMPREHENSIVE LOSS

The following tables summarize the changes in accumulated balances of other comprehensive income (loss), net of taxes:

	Three months ended March 31, 2024 (unaudited)									Three months ended March 31, 2023 (unaudited)
	Unrealized gains (losses) on available- for- sale marketable securities			Unrealized gains (losses) on cash flow hedges			Total			Unrealized gains (losses) on available- for- sale marketable securities			Unrealized gains (losses) on cash flow hedges			Total

Beginning balance	$	(3,317	)	$	988		$	(2,329	)	$	(6,142	)	$	(107	)	$	(6,249	)
Other comprehensive income (loss) before reclassifications		188			(195	)		(7	)		684			(426	)		258
Amounts reclassified from accumulated other comprehensive income (loss)		(4	)		(380	)		(384	)		(92	)		173			81
Net current period other comprehensive income (loss)		184			(575	)		(391	)		592			(253	)		339
Ending balance	$	(3,133	)	$	413		$	(2,720	)	$	(5,550	)	$	(360	)	$	(5,910	)

The following table provides details about reclassifications out of accumulated other comprehensive income (loss):

Details about Accumulated Other Comprehensive Income (Loss) Components	Amount Reclassified from Accumulated Other Comprehensive Income (Loss)					Affected Line Item in the Statements of Income (Loss)

	Three months ended March 31,
	2024 (unaudited)		2023 (unaudited)
Unrealized losses on cash flow hedges	$	8	$	(4	)	Cost of revenues
		324		(147	)	Research and development
		9		(4	)	Sales and marketing
		39		(16	)	General and administrative
		380		(171	)	Total, before income taxes
		—		2		Income tax expense (benefit)
		380		(173	)	Total, net of income taxes
Unrealized gains on available-for-sale marketable securities		4		92		Financial income (loss), net
		—		—		Income tax expense (benefit)
		4		92		Total, net of income taxes
	$	384	$	(81	)	Total, net of income taxes

Note 14 - Share Repurchase Program

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Treasury Stock [Text Block]

NOTE 14:

SHARE REPURCHASE PROGRAM

Insider Trading Arrangements

3 Months Ended

Mar. 31, 2024

Insider Trading Arr Line Items

Material Terms of Trading Arrangement [Text Block]

Item 5

OTHER INFORMATION

Rule 10b5-1 Arrangement Adopted [Flag]

false

Non-Rule 10b5-1 Arrangement Adopted [Flag]

false

Rule 10b5-1 Arrangement Terminated [Flag]

false

Non-Rule 10b5-1 Arrangement Terminated [Flag]

false

Significant Accounting Policies (Policies)	3 Months Ended
Significant Accounting Policies (Policies)	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	*Basis of Presentation* The interim condensed consolidated financial statements have been prepared according to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”). The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024, are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2023, contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 7, 2024, have been applied consistently in these unaudited interim condensed consolidated financial statements.
New Accounting Pronouncements, Policy [Policy Text Block]	*Accounting Standards Recently Adopted by the Company* In June 2022, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The guidance is effective for annual periods beginning after December 15, 2023, with early adoption permitted. The Company adopted ASU 2022-03 as of January 1, 2024. The adoption did not result in a material impact on the Company's interim condensed financial statements. *Accounting Standards Recently Issued, Not Yet Adopted by the Company* In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09.
Use of Estimates, Policy [Policy Text Block]	*Use of Estimates* The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, the reported amounts of revenues and expenses during the reporting period, and amounts classified as a discontinued operation. Actual results could differ from those estimates.

Note 4 - Held for Sale and Discontinued Operation (Tables)

3 Months Ended

Mar. 31, 2024

Notes Tables

Disposal Groups, Including Discontinued Operations [Table Text Block]

	Three months ended March 31, 2023 (unaudited)
Revenues	$	2,473
Cost of revenue		1,807
Gross profit		666
Operating expenses:
Research and development, net		2,117
Sales and marketing		326
General and administrative		221
Amortization of intangible assets		175
Total operating expenses		2,839
Operating loss		(2,173	)
Financial income, net		—
Loss from discontinued operations before taxes on income		(2,173	)
Income tax expense		—
Net loss from discontinued operation	$	(2,173	)

Three months

ended March

31, 2023

(unaudited)

Net cash flows used in operating activities (*)

(1,230

)

Note 5 - Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2024

Notes Tables

Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]

Remainder

of 2024

2025

2026 and

thereafter

Licensing and related revenues

4,028

1,015

322

Disaggregation of Revenue [Table Text Block]

	Three months ended March 31, 2024 (unaudited)						Three months ended March 31, 2023 (unaudited)
	Licensing and related revenues		Royalties		Total		Licensing and related revenues		Royalties		Total
Geography
United States	$	383	$	2,155	$	2,538	$	702	$	1,650	$	2,352
Europe and Middle East		601		911		1,512		1,950		859		2,809
Asia Pacific		10,417		7,592		18,009		15,121		5,505		20,626
Other		13		—		13		475		—		475
Total	$	11,414	$	10,658	$	22,072	$	18,248	$	8,014	$	26,262

Use cases for the Company’s technology portfolio
Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT)	$	10,067	$	7,939	$	18,006	$	15,924	$	5,665	$	21,589
Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI)		1,347		2,719		4,066		2,324		2,349		4,673
Total	$	11,414	$	10,658	$	22,072	$	18,248	$	8,014	$	26,262

Timing of revenue recognition
Products transferred at a point in time	$	9,453	$	10,658	$	20,111	$	14,621	$	8,014	$	22,635
Products and services transferred over time		1,961		—		1,961		3,627		—		3,627
Total	$	11,414	$	10,658	$	22,072	$	18,248	$	8,014	$	26,262

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

	March 31, 2024		December 31, 2023

Trade receivables	$	14,052	$	8,433
Unbilled receivables (associated with licensing and related revenue)		9,600		9,735
Unbilled receivables (associated with royalties)		9,983		12,139
Deferred revenues (short-term contract liabilities)		2,479		3,018

Note 5 - Leases (Tables)

3 Months Ended

Mar. 31, 2024

Notes Tables

Lease, Cost [Table Text Block]

March 31, 2024

(Unaudited)

Weighted average remaining lease term (years)

3.97

Weighted average discount rates

4.00

	Three months ended March 31,
	2024		2023
	(unaudited)		(unaudited)

Operating lease cost	$	663	$	753
Cash payments for operating leases		622		727

Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]

The remainder of 2024	$2,082
2025		2,027
2026		880
2027		640
2028		332
2029 and thereafter		621
Total undiscounted cash flows		6,582
Less imputed interest		423
Present value of lease liabilities	$	6,159

Note 7 - Marketable Securities (Tables)

3 Months Ended

Mar. 31, 2024

Notes Tables

Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]

	March 31, 2024 (Unaudited)
	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Available-for-sale - matures within one year:
Corporate bonds	$	49,434	$	45	$	(743	)	$	48,736

Available-for-sale - matures after one year through three years:
Corporate bonds		80,935		127		(2,928	)		78,134
Total
	$	130,369	$	172	$	(3,671	)	$	126,870

	December 31, 2023
	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Available-for-sale - matures within one year:
Corporate bonds	$	27,690	$	4	$	(243	)	$	27,451

Available-for-sale - matures after one year through three years:
Corporate bonds		108,700		278		(3,734	)		105,244

Total	$	136,390	$	282	$	(3,977	)	$	132,695

Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]

	Less than 12 months					12 months or greater
	Fair value		Gross unrealized loss			Fair value		Gross unrealized loss
As of March 31, 2024 (unaudited)	$	23,123	$	(147	)	$	76,036	$	(3,524	)
As of December 31, 2023	$	18,193	$	(49	)	$	86,643	$	(3,928	)

Schedule of Realized Gain (Loss) [Table Text Block]

	Three months ended March 31,
	2024			2023
	(unaudited)			(unaudited)

Gross realized gains from sale of available-for-sale marketable securities	$	9		$	92
Gross realized losses from sale of available-for-sale marketable securities	$	(5	)	$	—

Note 8 - Fair Value Measurement (Tables)

3 Months Ended

Mar. 31, 2024

Notes Tables

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

Description	March 31, 2024 (unaudited)		Level I (unaudited)		Level II (unaudited)		Level III (unaudited)
Assets:
Marketable securities:
Corporate bonds	$	126,870		—	$	126,870		—
Foreign exchange contracts		413		—		413		—
Investments in marketable equity securities		346		346		—		—

Description	December 31, 2023		Level I		Level II		Level III
Assets:
Marketable securities:
Corporate bonds	$	132,695		—	$	132,695		—
Foreign exchange contracts		988		—		988		—
Investments in marketable equity securities		406		406		—		—

Note 9 - Geographic Information and Major Customer Data (Tables)

3 Months Ended

Mar. 31, 2024

Notes Tables

Revenue from External Customers by Geographic Areas [Table Text Block]

	Three months ended March 31,
	2024 (unaudited)		2023 (unaudited)
Revenues based on customer location:
United States	$	2,538	$	2,352
Europe and Middle East		1,512		2,809
Asia Pacific (1)		18,009		20,626
Other		13		475
	$	22,072	$	26,262

(1) China	$	13,592	$	17,763

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

	Three months ended March 31,
	2024 (unaudited)			2023 (unaudited)

Customer A		15	%			*)
Customer B		14	%			*)
Customer C			*)		14	*)

*) Less than 10%

Note 10 - Net Loss Per Share of Common Stock (Tables)

3 Months Ended

Mar. 31, 2024

Notes Tables

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three months ended March 31,
	2024 (unaudited)			2023 (unaudited)
Numerator:
Net loss from continuing operation	$	(5,448	)	$	(2,699	)
Net loss from discontinued operation		—			(2,173	)
Net loss	$	(5,448	)	$	(4,872	)
Denominator (in thousands):
Basic and diluted weighted-average common stock outstanding		23,508			23,334

Basic and diluted net loss per share from continuing operation	$	(0.23	)	$	(0.12	)
Basic and diluted net loss per share from discontinued operation	$	—		$	(0.09	)
Basic and diluted net loss per share	$	(0.23	)	$	(0.21	)

Note 11 - Common Stock and Stock-based Compensation Plans (Tables)

3 Months Ended

Mar. 31, 2024

Notes Tables

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

	Number of options			Weighted average exercise price		Weighted average remaining contractual term		Aggregate intrinsic value
Outstanding as of December 31, 2023		99,425		$	20.74		2.5	$	316
Granted		—			—
Exercised		(13,000	)		14.77
Forfeited or expired		—			—
Outstanding as of March 31, 2024 (unaudited)		86,425		$	21.64		2.6	$	213
Exercisable as of March 31, 2024 (unaudited)		67,000		$	21.64		1.5	$	192

Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]

	Number of RSUs and PSUs			Weighted Average Grant- Date Fair Value
Unvested as of December 31, 2023		1,281,751		$	24.97
Granted		414,572			17.21
Vested		(112,076	)		36.71
Forfeited or expired		(110,218	)		19.07
Unvested as of March 31, 2024 (unaudited)		1,474,029		$	22.34

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

	Three months ended March 31,
	2024 (unaudited)		2023 (unaudited)
Cost of revenue	$	203	$	206
Research and development, net		2,007		2,102
Sales and marketing		365		378
General and administrative		996		866
Total equity-based compensation expense from continuing operations		3,571		3,552
Equity-based compensation expense included in discontinued operations		—		307
Total equity-based compensation expense	$	3,571	$	3,859

Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]

	Three months ended March 31
	2024 (unaudited)			2023 (unaudited)
Expected dividend yield		0	%		0	%
Expected volatility		46	%		45	%
Risk-free interest rate		5.3	%		4.8	%
Contractual term of up to (months)		6			6

Note 12 - Derivatives and Hedging Activities (Tables)

3 Months Ended

Mar. 31, 2024

Notes Tables

Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]

	March 31, 2024		December 31, 2023
Derivative assets:
Derivatives designated as cash flow hedging instruments:
Foreign exchange forward contracts	$	413	$	988
Total	$	413	$	988

	Three months ended March 31,
	2024 (unaudited)			2023 (unaudited)
Derivatives designated as cash flow hedging instruments:
Foreign exchange option contracts	$	—		$	(105	)
Foreign exchange forward contracts		(195	)		(320	)
	$	(195	)	$	(425	)

Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]

	Three months ended March 31,
	2024 (unaudited)			2023 (unaudited)
Derivatives designated as cash flow hedging instruments:
Foreign exchange option contracts	$	—		$	—
Foreign exchange forward contracts		(380	)		171
	$	(380	)	$	171

Note 13 - Accumulated Other Comprehensive Income (Loss) (Tables)

3 Months Ended

Mar. 31, 2024

Notes Tables

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

	Three months ended March 31, 2024 (unaudited)									Three months ended March 31, 2023 (unaudited)
	Unrealized gains (losses) on available- for- sale marketable securities			Unrealized gains (losses) on cash flow hedges			Total			Unrealized gains (losses) on available- for- sale marketable securities			Unrealized gains (losses) on cash flow hedges			Total

Beginning balance	$	(3,317	)	$	988		$	(2,329	)	$	(6,142	)	$	(107	)	$	(6,249	)
Other comprehensive income (loss) before reclassifications		188			(195	)		(7	)		684			(426	)		258
Amounts reclassified from accumulated other comprehensive income (loss)		(4	)		(380	)		(384	)		(92	)		173			81
Net current period other comprehensive income (loss)		184			(575	)		(391	)		592			(253	)		339
Ending balance	$	(3,133	)	$	413		$	(2,720	)	$	(5,550	)	$	(360	)	$	(5,910	)

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]

Details about Accumulated Other Comprehensive Income (Loss) Components	Amount Reclassified from Accumulated Other Comprehensive Income (Loss)					Affected Line Item in the Statements of Income (Loss)

	Three months ended March 31,
	2024 (unaudited)		2023 (unaudited)
Unrealized losses on cash flow hedges	$	8	$	(4	)	Cost of revenues
		324		(147	)	Research and development
		9		(4	)	Sales and marketing
		39		(16	)	General and administrative
		380		(171	)	Total, before income taxes
		—		2		Income tax expense (benefit)
		380		(173	)	Total, net of income taxes
Unrealized gains on available-for-sale marketable securities		4		92		Financial income (loss), net
		—		—		Income tax expense (benefit)
		4		92		Total, net of income taxes
	$	384	$	(81	)	Total, net of income taxes

Note 3 - Acquisition (Details Textual) - VisiSonics [Member] $ in Thousands	1 Months Ended
	Jan. 31, 2024 USD ($)
Asset Acquisition, Consideration Transferred	$ 750
Asset Acquisition, Contingent Consideration, Liability	$ 2,100

Note 4 - Held for Sale and Discontinued Operation (Details Textual) - USD ($) $ in Thousands		3 Months Ended
	Sep. 14, 2023	Mar. 31, 2023
Amortization of intangible assets		$ 175
Discontinued Operations [Member]
Amortization of intangible assets		$ 492
Intrinsix Corp. [Member]
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred	$ 240
Intrinsix Corp. [Member]
Sale of Stock, Consideration	35,000
Sale of Stock, Amount Held for Post Closing Price Adjustment	300
Sale of Stock, Amount Held for Indemnification Obligations	$ 3,500

Note 4 - Held for Sale and Discontinued Operation - Schedule of Disposal Groups Including Discontinued Operations (Details) - USD ($)
$ in Thousands

3 Months Ended

Mar. 31, 2024

Mar. 31, 2023

Revenues

$ 2,473

Net cash flows used in operating activities (*)

^[1]

(1,230)

Cost of revenue

1,807

Gross profit

666

Research and development, net

2,117

Sales and marketing

326

General and administrative

221

Amortization of intangible assets

175

Total operating expenses

2,839

Operating loss

(2,173)

Financial income, net

Loss from discontinued operations before taxes on income

(2,173)

Income tax expense

Net loss from discontinued operation

$ 0

$ (2,173)

[1]	Amortization and depreciation allocated to discontinued operation for the three-month period ended March 31, 2023 amounted to $492.

Note 5 - Revenue Recognition (Details Textual) $ in Thousands	3 Months Ended
	Jun. 30, 2023 USD ($)
Contract with Customer, Liability, Revenue Recognized	$ 1,179

Note 5 - Revenue Recognition - Remaining Performance Obligation 2 (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01
Licensing, NRE and related revenues	$ 4,028
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Licensing, NRE and related revenues	$ 1,015
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Licensing, NRE and related revenues	$ 322
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	1 year

Note 5 - Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands

3 Months Ended

Mar. 31, 2024

Mar. 31, 2023

Revenue

$ 22,072

$ 26,262

Transferred at Point in Time [Member]

Revenue

20,111

22,635

Transferred over Time [Member]

Revenue

1,961

3,627

Connectivity Products [Member]

Revenue

18,006

21,589

Smart Sensing Products [Member]

Revenue

4,066

4,673

UNITED STATES

Revenue

2,538

2,352

Europe and Middle East [Member]

Revenue

1,512

2,809

Asia Pacific [Member]

Revenue

^[1]

18,009

20,626

475

11,414

18,248

License [Member] | Transferred at Point in Time [Member]

Revenue

9,453

14,621

License [Member] | Transferred over Time [Member]

Revenue

1,961

3,627

License [Member] | Connectivity Products [Member]

Revenue

10,067

15,924

License [Member] | Smart Sensing Products [Member]

Revenue

1,347

2,324

License [Member] | UNITED STATES

Revenue

383

702

License [Member] | Europe and Middle East [Member]

Revenue

601

1,950

License [Member] | Asia Pacific [Member]

Revenue

10,417

15,121

License [Member] | Other [Member]

Revenue

475

Royalty [Member]

Revenue

10,658

8,014

Royalty [Member] | Transferred at Point in Time [Member]

Revenue

10,658

8,014

Royalty [Member] | Connectivity Products [Member]

Revenue

7,939

5,665

Royalty [Member] | Smart Sensing Products [Member]

Revenue

2,719

2,349

Royalty [Member] | UNITED STATES

Revenue

2,155

1,650

Royalty [Member] | Europe and Middle East [Member]

Revenue

911

859

Royalty [Member] | Asia Pacific [Member]

Revenue

$ 7,592

$ 5,505

[1]

China

Note 5 - Revenue Recognition - Assets and Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Deferred revenues (short-term contract liabilities)	$ 2,479	$ 3,018
Trade Receivables [Member]
Trade receivables	14,052	8,433
Accrued Revenues [Member] \| Licensing and Other [Member]
Trade receivables	9,600	9,735
Accrued Revenues [Member] \| Royalty [Member]
Trade receivables	9,983	12,139
Deferred Revenue [Member]
Deferred revenues (short-term contract liabilities)	$ 2,479	$ 3,018

Note 5 - Leases -Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Weighted average remaining lease term (years) (Year)	3 years 11 months 19 days
Operating lease cost	$ 663	$ 753
Weighted average discount rates	4.00%
Cash payments for operating leases	$ 622	$ 727

Note 5 - Leases - Maturities of Lease Liabilities (Details) $ in Thousands	Mar. 31, 2024 USD ($)
The remainder of 2023	$ 2,082
2024	2,027
2025	880
2026	640
2027	332
2028 and thereafter	621
Total undiscounted cash flows	6,582
Less imputed interest	423
Present value of lease liabilities	$ 6,159

Note 7 - Marketable Securities - Available-for-sale Marketable Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Marketable securities	$ 126,870	$ 132,695
Corporate Bonds [Member]
Available For Sale Securities Debt Maturities Within One Year Amortized Cost	49,434	27,690
Available-for-sale - matures within one year, Gross unrealized gains	45	4
Available-for-sale - matures within one year, Gross unrealized losses	(743)	(243)
Available-for-sale- matures within one year, Fair Value	48,736	27,451
Available-for-sale - matures after one year through five years, amortized cost	80,935	108,700
Available-for-sale - matures after one year through five years, Gross unrealized gains	127	278
Available for Sale Matures after One Year Through Five Years, Gross Unrealized Loss	(2,928)	(3,734)
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value	78,134	105,244
Debt Securities, Available-for-Sale, Amortized Cost	130,369	136,390
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	172	282
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	(3,671)	(3,977)
Marketable securities	$ 126,870	$ 132,695

Note 7 - Marketable Securities - Summary of Gross Unrealized Losses and Fair Values on Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Less than 12 months, Fair value	$ 23,123	$ 18,193
Less than 12 months, Gross unrealized loss	(147)	(49)
12 months or greater, Fair value	76,036	86,643
12 months or greater, Gross unrealized loss	$ (3,524)	$ (3,928)

Note 7 - Marketable Securities - Summary of Gross Realized Gains and Losses from Sale of Available-for-sale Marketable Securities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Gross realized gains from sale of available-for-sale marketable securities	$ 9	$ 92
Gross realized losses from sale of available-for-sale marketable securities	$ (5)	$ 0

Note 8 - Fair Value Measurement - Assets and Liabilities Measured at Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Corporate bonds	$ 126,870	$ 132,695
Foreign exchange contracts	413	988
Investments in marketable equity securities	346	406
Fair Value, Inputs, Level 1 [Member]
Foreign exchange contracts	0	0
Investments in marketable equity securities	346	406
Fair Value, Inputs, Level 2 [Member]
Foreign exchange contracts	413	988
Investments in marketable equity securities	0	0
Fair Value, Inputs, Level 3 [Member]
Foreign exchange contracts	0	0
Investments in marketable equity securities	0	0
Corporate Bonds [Member]
Corporate bonds	126,870	132,695
Corporate Bonds [Member] \| Fair Value, Inputs, Level 1 [Member]
Corporate bonds	0	0
Corporate Bonds [Member] \| Fair Value, Inputs, Level 2 [Member]
Corporate bonds	126,870	132,695
Corporate Bonds [Member] \| Fair Value, Inputs, Level 3 [Member]
Corporate bonds	$ 0	$ 0

Note 9 - Geographic Information and Major Customer Data (Details Textual)	3 Months Ended
	Mar. 31, 2024
Number of Reportable Segments	1

Note 9 - Geographic Information and Major Customer Data - Revenues Based On Customer Location (Details) - USD ($)
$ in Thousands

3 Months Ended

Mar. 31, 2024

Mar. 31, 2023

Revenue

$ 22,072

$ 26,262

UNITED STATES

Revenue

2,538

2,352

Europe and Middle East [Member]

Revenue

1,512

2,809

Asia Pacific [Member]

Revenue

^[1]

18,009

20,626

475

$ 13,592

$ 17,763

[1]

China

Note 9 - Geographic Information and Major Customer Data - Major Customers Data As Percentage of Total Revenues (Details) - Revenue from Contract with Customer Benchmark [Member] - Customer Concentration Risk [Member]	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Customer A [Member]
Percentage of total revenues	15.00%
Customer C [Member]
Percentage of total revenues		14.00%

Note 10 - Net Loss Per Share of Common Stock (Details Textual) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,560,454	1,181,119

Note 10 - Net Income (Loss) Per Share of Common Stock - Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net loss	$ (5,448)	$ (2,699)
Net loss from discontinued operation	0	(2,173)
Net loss:	$ (5,448)	$ (4,872)
Basic and diluted (in shares)	23,508	23,334
Basic and diluted (in dollars per share)	$ (0.23)	$ (0.12)
Basic and diluted net loss per share from discontinued operation (in dollars per share)	0	(0.09)
Basic and diluted net loss per share (in dollars per share)	$ (0.23)	$ (0.21)

Note 11 - Common Stock and Stock-based Compensation Plans (Details Textual) - USD ($) $ in Thousands			3 Months Ended
	Mar. 31, 2024	Feb. 12, 2024	Mar. 31, 2024	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Options and Stock Appreciation Rights, Outstanding Number	86,425		86,425	99,425
Chief Financial Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded		5,344
Chief Operating Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded		4,372
Chief Commercial Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded		3,609
Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 184		$ 184
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition			2 years 2 months 12 days
Restricted Stock Units (RSUs) [Member] \| Vesting on February 17, 2024 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		33.40%
Restricted Stock Units (RSUs) [Member] \| Vesting on February 17, 2025 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		33.30%
Restricted Stock Units (RSUs) [Member] \| Vesting on February 17, 2026 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		33.30%
Restricted Stock Units (RSUs) [Member] \| Employees [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period	3 years
Restricted Stock Units (RSUs) [Member] \| Non-employee Director [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period	2 years
Restricted Stock Units (RSUs) [Member] \| Non-employee Director [Member] \| Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period	1 year
Short-Term Executive PSUs [Member] \| Goals One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage		90.00%
Short-Term Executive PSUs [Member] \| Goals One [Member] \| Full Vesting Based on The Achievement of 2022 License Target [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		50.00%
Short-Term Executive PSUs [Member] \| Goals One [Member] \| Increase in Eligible PSUs, Percent [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage		2.00%
Short-Term Executive PSUs [Member] \| Goals Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		25.00%
Short-Term Executive PSUs [Member] \| Goals Two [Member] \| Increase in Eligible PSUs, Percent [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage		2.00%
Short-Term Executive PSUs [Member] \| Goals Two [Member] \| Vesting Based on Actual Return Being at Least 90 Percent of S&P500 Index [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		25.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage		90.00%
Short-Term Executive PSUs [Member] \| Goals Two [Member] \| Vesting Based on Actual Return In Excess of 100 Percent of S&P500 Index [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage		100.00%
Short-Term Executive PSUs [Member] \| Goals Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		25.00%
Short-Term Executive PSUs [Member] \| Goals Three [Member] \| Increase in Eligible PSUs, Percent [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage		2.00%
Short-Term Executive PSUs [Member] \| Goals Three [Member] \| Full Vesting Based on The Achievement of Positive Shareholder Return [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		25.00%
Short-Term Executive PSUs [Member] \| Goals Three [Member] \| Vesting Based on Actual Return Being at Least 90 Percent of Russel 2000 Index [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage		90.00%
Short-Term Executive PSUs [Member] \| Goals Three [Member] \| Vesting Based on Actual Return In Excess of 100 Percent of Russel 2000 Index [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage		100.00%
Short-Term Executive PSUs [Member] \| Vesting on February 16, 2025 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		33.40%
Short-Term Executive PSUs [Member] \| Vesting on February 16, 2026 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		33.30%
Short-Term Executive PSUs [Member] \| Vesting on February 16, 2027 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		33.30%
Short-Term Executive PSUs [Member] \| Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded, Percentage		60.00%
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded		29,986
Short-Term Executive PSUs [Member] \| Chief Executive Officer [Member] \| Goals One [Member] \| Increase in Eligible PSUs, Percent [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage		3.00%
Short-Term Executive PSUs [Member] \| Chief Executive Officer [Member] \| Goals Two [Member] \| Increase in Eligible PSUs, Percent [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage		3.00%
Short-Term Executive PSUs [Member] \| Chief Executive Officer [Member] \| Goals Three [Member] \| Increase in Eligible PSUs, Percent [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage		3.00%
Short-Term Executive PSUs [Member] \| CFO, COO, and CCO [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded, Percentage		40.00%
RSUs and PSUs [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 22,830		$ 22,830
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition			1 year 7 months 6 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period			414,572
Maximum [Member] \| Short-Term Executive PSUs [Member] \| Goals One [Member] \| Vesting Based on Achievement In Excess of 90 Percent [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		99.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage		99.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage		120.00%
Maximum [Member] \| Short-Term Executive PSUs [Member] \| Goals Two [Member] \| Vesting Based on Actual Return Being at Least 90 Percent of S&P500 Index [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		99.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage		99.00%
Maximum [Member] \| Short-Term Executive PSUs [Member] \| Goals Two [Member] \| Vesting Based on Actual Return In Excess of 100 Percent of S&P500 Index [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage		120.00%
Maximum [Member] \| Short-Term Executive PSUs [Member] \| Goals Three [Member] \| Vesting Based on Actual Return Being at Least 90 Percent of Russel 2000 Index [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		99.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage		99.00%
Maximum [Member] \| Short-Term Executive PSUs [Member] \| Goals Three [Member] \| Vesting Based on Actual Return In Excess of 100 Percent of Russel 2000 Index [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage		120.00%
Minimum [Member] \| Short-Term Executive PSUs [Member] \| Goals One [Member] \| Vesting Based on Achievement In Excess of 90 Percent [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		91.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage		1.00%
Minimum [Member] \| Short-Term Executive PSUs [Member] \| Goals Two [Member] \| Vesting Based on Actual Return Being at Least 90 Percent of S&P500 Index [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		91.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage		90.00%
Minimum [Member] \| Short-Term Executive PSUs [Member] \| Goals Two [Member] \| Vesting Based on Actual Return In Excess of 100 Percent of S&P500 Index [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage		1.00%
Minimum [Member] \| Short-Term Executive PSUs [Member] \| Goals Three [Member] \| Vesting Based on Actual Return Being at Least 90 Percent of Russel 2000 Index [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		91.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage		90.00%
Minimum [Member] \| Short-Term Executive PSUs [Member] \| Goals Three [Member] \| Vesting Based on Actual Return In Excess of 100 Percent of Russel 2000 Index [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage		1.00%
The2011 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options and Stock Appreciation Rights Vesting Percentage, Year One	25.00%		25.00%
Share-based Compensation Arrangement by Share-based Payment Award, Remaining Vesting Period			36 months
The2011 Stock Incentive Plan [Member] \| Restricted Stock Units (RSUs) [Member] \| Non-employee Director [Member] \| Vesting After the First Anniversary Grant Date [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		50.00%
The2011 Stock Incentive Plan [Member] \| Restricted Stock Units (RSUs) [Member] \| Chief Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period		33,318
The2011 Stock Incentive Plan [Member] \| Restricted Stock Units (RSUs) [Member] \| Chief Financial Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period		20,043
The2011 Stock Incentive Plan [Member] \| Restricted Stock Units (RSUs) [Member] \| Chief Operating Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period		16,399
The2011 Stock Incentive Plan [Member] \| Restricted Stock Units (RSUs) [Member] \| Chief Commercial Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period		13,535
The2011 Stock Incentive Plan [Member] \| Performance Share Units [Member] \| Chief Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period		49,978
The2011 Stock Incentive Plan [Member] \| Performance Share Units [Member] \| Chief Financial Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period		13,362
The2011 Stock Incentive Plan [Member] \| Performance Share Units [Member] \| Chief Operating Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period		10,932
The2011 Stock Incentive Plan [Member] \| Performance Share Units [Member] \| Chief Commercial Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period		9,023
The2011 Stock Incentive Plan [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period			4 years
Share-Based Payment Arrangement, Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options and Stock Appreciation Rights, Outstanding Number	0		0	0

Note 11 - Common Stock and Stock-based Compensation Plans - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Outstanding, Number of shares (in shares)	99,425
Outstanding, Weighted average exercise price (in dollars per share)	$ 20.74
Outstanding, Weighted average remaining contractual term (Year)	2 years 7 months 6 days	2 years 6 months
Outstanding, Aggregated intrinsic value	$ 213	$ 316
Exercised, Number of shares (in shares)	(13,000)
Exercised, Weighted average exercise price (in dollars per share)	$ 14.77
Outstanding, Number of shares (in shares)	86,425	99,425
Outstanding, Weighted average exercise price (in dollars per share)	$ 21.64	$ 20.74
Exercisable, Number of shares (in shares)	67,000
Exercisable, Weighted average exercise price (in dollars per share)	$ 21.64
Exercisable, Weighted average remaining contractual term (Year)	1 year 6 months
Exercisable, Aggregated intrinsic value	$ 192

Note 11 - Common Stock and Stock-based Compensation Plans - Summary of Restricted Stock Units Activity (Details) - RSUs and PSUs [Member]	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Unvested, number (in shares) \| shares	1,281,751
Unvested, weighted average fair value (in dollars per share) \| $ / shares	$ 24.97
Granted, number (in shares) \| shares	414,572
Granted, weighted average fair value (in dollars per share) \| $ / shares	$ 17.21
Vested, number (in shares) \| shares	(112,076)
Vested, weighted average fair value (in dollars per share) \| $ / shares	$ 36.71
Forfeited or expired, number (in shares) \| shares	(110,218)
Forfeited or expired, weighted average fair value (in dollars per share) \| $ / shares	$ 19.07
Unvested, number (in shares) \| shares	1,474,029
Unvested, weighted average fair value (in dollars per share) \| $ / shares	$ 22.34

Note 11 - Common Stock and Stock-based Compensation Plans - Equity-based Compensation Expense Included in Interim Condensed Consolidated Statements of Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Total equity-based compensation expense	$ 3,571	$ 3,859
Cost of Revenues [Member]
Total equity-based compensation expense	203	206
Research and Development, Net [Member]
Total equity-based compensation expense	2,007	2,102
Sales and Marketing [Member]
Total equity-based compensation expense	365	378
General and Administrative [Member]
Total equity-based compensation expense	996	866
Total Equity-based Compensation Expense From Continuing Operations [Member]
Total equity-based compensation expense	3,571	3,552
Equity-based Compensation Expense Included in Discontinued Operations [Member]
Total equity-based compensation expense	$ 0	$ 307

Note 11 - Common Stock and Stock-based Compensation Plans - Valuation Assumptions (Details) - The 2002 Employee Stock Purchase Plan [Member] - Purchase Rights [Member]	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Expected dividend yield		0.00%
Expected volatility	46.00%
Expected volatility		45.00%
Risk-free interest rate	5.30%
Risk-free interest rate		4.80%
Contractual term of (months) (Month)	6 months	6 months

Note 12 - Derivatives and Hedging Activities (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Derivative, Notional Amount	$ 8,700		$ 16,500
Derivative, Gain (Loss) on Derivative, Net	$ 380	$ 171

Note 12 - Derivatives and Hedging Activities - Effective Portion of the Gains and Losses on Derivative Instruments Designated (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Changes in unrealized gains (losses)	$ (195)	$ (425)
Foreign exchange forward contracts	413		$ 988
Cash Flow Hedging [Member]
Changes in unrealized gains (losses)	(195)	(425)
Derivative Asset, Total	413		988
Cash Flow Hedging [Member] \| Foreign Exchange Option [Member]
Changes in unrealized gains (losses)	0	(105)
Cash Flow Hedging [Member] \| Foreign Exchange Forward [Member]
Changes in unrealized gains (losses)	(195)	$ (320)
Foreign exchange forward contracts	$ 413		$ 988

Note 12 - Derivatives and Hedging Activities - Net (Gains) Losses Reclassified from Accumulated Other Comprehensive Loss (Details) - Derivatives Designated as Cash Flow Hedging Instruments [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Gain (loss) reclassified from accumulated OCI into income, Effective portion, Net, Total	$ (380)	$ 171
Foreign Exchange Option Contracts [Member]
Gain (loss) reclassified from accumulated OCI into income, Effective portion, Net, Total	0	0
Foreign Exchange Forward Contracts [Member]
Gain (loss) reclassified from accumulated OCI into income, Effective portion, Net, Total	$ (380)	$ 171

Note 13 - Accumulated Other Comprehensive Income (Loss) - Changes in Accumulated Balances of Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Balance	$ 264,341	$ 258,871
Balance	262,349	259,870
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]
Balance	(3,317)	(6,142)
Other comprehensive income (loss) before reclassifications	188	684
Amounts reclassified from accumulated other comprehensive loss	(4)	(92)
Net current period other comprehensive income (loss)	184	592
Balance	(3,133)	(5,550)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Balance	988	(107)
Other comprehensive income (loss) before reclassifications	(195)	(426)
Amounts reclassified from accumulated other comprehensive loss	(380)	173
Net current period other comprehensive income (loss)	(575)	(253)
Balance	413	(360)
AOCI Attributable to Parent [Member]
Balance	(2,329)	(6,249)
Other comprehensive income (loss) before reclassifications	(7)	258
Amounts reclassified from accumulated other comprehensive loss	(384)	81
Net current period other comprehensive income (loss)	(391)	339
Balance	$ (2,720)	$ (5,910)

Note 13 - Accumulated Other Comprehensive Income (Loss) - Reclassifications Out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cost of Revenues	$ (2,503)	$ (3,508)
Research and development	(17,991)	(18,674)
Sales and marketing	(2,816)	(2,719)
General and administrative	(3,572)	(3,827)
Total, before income taxes	(3,763)	(1,282)
Income tax expense (benefit)	1,685	1,417
Net loss	(5,448)	(4,872)
Financial income, net	1,257	1,455
Reclassification out of Accumulated Other Comprehensive Income [Member]
Net loss	384	(81)
Unrealized Gains (Losses) on Cash Flow Hedges [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member]
Cost of Revenues	8	(4)
Research and development	324	(147)
Sales and marketing	9	(4)
General and administrative	39	(16)
Total, before income taxes	380	(171)
Income tax expense (benefit)	0	2
Net loss	380	(173)
Unrealized Gains (Losses) on Available-for-sale Marketable Securities [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member]
Income tax expense (benefit)	0	0
Net loss	4	92
Financial income, net	$ 4	$ 92

Note 14 - Share Repurchase Program (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Treasury Stock, Shares, Acquired	56,872	0
Shares Acquired, Average Cost Per Share (in dollars per share)	$ 22.48
Treasury Stock Value Acquired Weighted Average Method	$ 1,278
Share Repurchase Program, Remaining Authorized, Number of Shares	643,128